Download Nagi S. El Saghir, MD, FACP - American University of Beirut

Nagi S. El Saghir, MD, FACP
Curriculum Vitae, September 2015
@NagiSaghir
www.facebook.com/ Nagi El Saghir
1. Personal and Professional Information:
Professor of Clinical Medicine, American University of Beirut, Beirut, Lebanon
Director, Breast Center of Excellence, Naef K. Basile Cancer Institute, AUBMC
President, Lebanese Breast Cancer Foundation, Beirut, Lebanon
Co-Chair, ASCO Guidelines Advisory Group, Clinical Practice Guidelines Committee,
American Society of Clinical Oncology (2013-Present)
Member, ASCO Global Oncology Task Force (2014-2016)
Member, ASCO International Affairs Committee (2012-2015)
Chair, ASCO International Affairs Committee (2013-2014)
Member, ESMO Developing Countries Task Force (2008-2013)
Member, ESMO Emerging Countries Committee (2008-Present)
BHGI Panelist and co-author: Breast Health Global Initiative (2007, 2011, 2013)
ABC Panelist and co-author: Advanced Breast Cancer International Consensus Guidelines
(ABC1: 2011, ABC2: 2013, ABC3:2015)
Founding President, Lebanese Society of Medical Oncology (1997-1998)
President, Lebanese Society of Medical Oncology (1998-2000)
President, Lebanese Society of Internal Medicine (2002-2004)
President, and Co-Chair, Best of ASCO Lebanon (2006-2015)
Editorial Board, Journal of Global Oncology (2015-Present)
International Editor, Journal of Clinical Oncology (2000-Present)
Editorial Advisory Board: The Breast (2013-Present)
Deputy Editor, The Breast (2006-2013)
Author, ABC of Breast Diseases, First Edition 2004, Second Edition 2006, Third Fully
Updated Edition 2014;
Author, Lebanese Breast Cancer Foundation Awareness Book: LBCF Knowledge: Roadmap to
Cure 2011, 2nd Edition 2014
Medical Degree and Certifications:
1978 Doctor of Medicine, Free University of Brussels, Brussels, Belgium
1978 Educational Commission for Foreign Medical Graduates (ECFMG)
1979 Visa Qualifying Examination (VQE)
1980 Federal Licensing Examination (FLEX)
1981 American Board of Internal Medicine
1985 American Board of Internal Medicine - Medical Oncology
Honors and Awards:
National Cedar Medal of Lebanon (Ordre National du Cedre), Rank Officer, President of
Lebanon, 2014
Medal of Honor for Achievements (Wissam Al-Istihqaq), President of Lebanon, 2002
Terry Fox Medal of Appreciation of Canadian Embassy of Beirut/CAAL, 2000
Medal of Appreciation, Lebanese Order of Physicians, 2002
Medal of Appreciation and Pride, Lebanese Women’s Rights League, 2002
Medal of Appreciation, American Alumni Association of Lebanon, 2002
Medal of Appreciation, The Lebanese Health Society, 2002
Medal of the Bint Jbeil Cultural Association, 2002
Medal of the Municipality of Bint Jbeil, 2002
Pan Arab Oncology Congress Award of Appreciation, Damascus, 2003
Pan Arab Oncology Congress Award of Appreciation, Cairo, Egypt, 2009
Cairo University Hospitals Medal of Acknowledgement for Contributions to Cancer Care in the
Arab World, December 2006
Certificate of Appreciation, Lebanese Society of Medical Oncology, 2004
Medal of Recognition, Lebanese Society of Medical Oncology, Annual Meeting, 2004
Jordan Oncology Society Award of Appreciation, April 2006
Lions International: Beirut Freedom Club 2007, Philadelphia Club 2007
Medal of Appreciation: National Guard Medical Services, Saudi Arabia 2009
Medal of Appreciation: Algeria Society of Oncology 2010
Best of ASCO in Lebanon Appreciation Award, 2006-2011
Outstanding Excellence Award, in Recognition for Exceptional Accomplishments: Lebanese
Society of Medical Oncology 2013
Minieh Arz Schools, Minieh, Tripoli, Lebanon 2015
Antranik Sports Club, Beirut, Lebanon 2015
Arab Medical Association Against Cancer AMAAC Recognition Award, March 2015
Author: ABC of Breast Diseases from Prevention to Treatment, Arab Scientific Publishers,
(ASP), Beirut, Lebanon January 2005. (Bestseller list, Beirut International Book Fair, December
2004): Second Edition: January 2006 (ASP)
Third Edition: ABC of Breast Diseases, Awareness, Prevention, Treatment: June 2013
Author: Awareness Road Map to Cure. Lebanese Breast Cancer Foundation, 2011, 2014
Specialty Editor: The Breast: 2006-2013
International Editor: Journal of Clinical Oncology (Middle East and Northern Africa Editions);
Editor, Middle East Edition: Cancer
Editorial Board: ASCO’s Journal of Global Oncology
Editorial Board: International Journal of Surgery 2005-present
Editorial Board: OncoTargets and Therapy: 2008-present
Consulting Editor: Lebanese Medical Journal: 1997-1999
Founding and Past-President: Lebanese Society of Medical Oncology LSMO (1997-2000)
Past-President: Lebanese Society of Internal Medicine (2002-2004)
Founding President: Lebanese Breast Cancer Foundation LBCF: Awareness – Taw3eiah: 2011
Coordinator and Chairman: Breast Tumor Clinics, Tumor Boards and Videolinks:
AUBMC, AUBMC-MD Anderson Cancer Center, Houston, Texas, and AUBMC-Memorial
Sloan Kettering Cancer Center, New York, NY
Breast Health Global Initiative: Panelist and Speaker, Budapest, Hungary, Oct. 2007
Breast Health Global Initiative: Co-Chair and Speaker, Chicago, Illinois, June 2010
Advanced Breast Cancer ABC1 International Consensus Conference: Panelist and Speaker,
Metastatic Breast Cancer 1, Lisbon, Portugal, November 3-5, 2011.
Advanced Breast Cancer ABC2 International Consensus Conference: Panelist and Speaker,
Metastatic Breast Cancer 1, Lisbon, Portugal, November 7-9, 2013.
AUB BCC1: Activity Director, AUB Annual Breast Cancer Conference, Beirut, Lebanon,
February 8-9, 2013
AUB BCC2: Activity Director, AUBMC Annual Breast Cancer Conference, Beirut, Lebanon,
February 14-15, 2014
AUB BCC3: Activity Director, AUBMC Annual Breast Cancer Conference, Beirut, Lebanon,
February 13-14, 2015
Coordinator, Breast Cancer National Task Force, Ministry of Health (2005-Present)
Breast October Month Awareness Committee: Ministry of Health of Lebanon (2002-Present)
President: Arab Breast Cancer Research Group 2004-2006
AMAAC-EASO: Arab-Medical Association Against Cancer – Euro-Arab School of Oncology
Scientific Committee 2009- present
AMAAC-EASO: Scientific Committee: Master class in Oncology 2011
EORTC (European Organization for Research and Treatment of Cancer): Breast Cancer
Group
ESMO (European Society for Medical Oncology) Regional Representative-ME: 2006-2008
ESMO Emerging Countries Committee: 2013-present (Previously: ESMO Developing
Countries Task Force DTCF 2006-2013)
ESO - Breast Cancer in Young Women: Co-Chairman (with Cornelius. van de Velde and
Umberto Veronesi): European School of Oncology Advanced Course: Breast Cancer Special
Issues in Young Women. September 2005
ASCO International Affairs Committee member: 2002-2005; Chair-Elect: 2012-2013;
Chair: 2013-2014.
ASCO International Travel Grant Working Group, member, 2003-2004, 2004-2005
ASCO International Development Education Award (IDEA) working Group 2005-06
ASCO MCMC (Multidisciplinary Cancer Management Course) Working Group: 2011present
ASCO (American Society of Clinical Oncology) Highlights (LSMO) Chairman: 1997-2005
Best of ASCO (LSMO & ASCO) Chair, Co-Chair, and President : 2006-2013
Best of ASCO 2006 Chair, Planning Committee, November 17-18, 2006, Beirut, Lebanon
Best of ASCO 2007 Chair, Planning Committee, July 6-7, 2007, Cairo, Egypt
Best of ASCO 2008 Co-Chair, Planning Committee, July 11-12, 2008, Faraya, Lebanon
Best of ASCO 2009 Co-Chair, Planning Committee, July 2009, Beirut, Lebanon
Best of ASCO 2010 President and Chair, Planning Committee, July 11-12, Beirut, LB
Best of ASCO 2011-15 President and Co-Chair, LSMO & BoA Scientific Committee
Best of San Antonio Breast Cancer Symposium (Scientific Committee) with Dr Omalkhair
Abulkhair, January 2006, 2007, 2008, 2009, 2010, 2011, 2011, Riyadh, SA
AUB–Hopkins Breast Cancer Course, Co-Director (with Dr N Khouri), MEMA, May 10-13,
2007
Pan Arab Cancer Congress PACC-4, Chairman, Scientific Committee, Arab Medical
Association Against Cancer, April 2002, Beirut, Lebanon
Pan Arab Cancer Bi-Annual and Annual Congresses: Scientific Committees.
King Faisal International Prize for Medicine: Member, Selection Committee 2002-2003
Marathons:
Terry Fox Marathon Steering Committee AUB Coordinator (1995-1997-2000)
Beirut Marathon Association 2009 Run Against Cancer: President, Medical Committee 2009
Board of Trustees (BOT) member, Beirut Marathon Association: Member (2007-present)
Date and Place of Birth: January 5, 1953, Lebanon
Nationality: USA & Lebanon
Spoken Languages: Arabic, English and French
2. Educational Background
Elementary School: 1964: Al-Irfan School, Borj Hammoud, Beirut, Lebanon
Middle School: 1967: Al-Tarbia Al-Haditha School, Nabaa, Beirut, Lebanon
High School: 1970: Raml-el-Zarif High School, Beirut, Lebanon
University Degree: (1971-1974)
Candidature en Sciences Medicales 1974
Universite Libre de Bruxelles - Faculte de Medecine
(Free University of Brussels, Brussels, Belgium)
Medical School: (1974 – 1978)
Docteur en Medecine, Chirurgie et Accouchement: MD 1978
Universite Libre de Bruxelles - Faculte de Medecine
(Free University of Brussels, Brussels, Belgium)
Internship and Residency: 1978–1979; 1979-1981: Internal Medicine: The Brooklyn Hospital,
Brooklyn, NY, 121 Dekalb Avenue, Brooklyn, NY 11201.
Affiliated Teaching Hospital of the State University of New York-Downstate Medical Center
Fellowship: 1981 – 1983: Hematology – Oncology: St. Luke's - Roosevelt Hospital Center,
Amsterdam Ave & 114th street, NY, NY 10025.
A University Teaching Hospital of Columbia University College of Physicians and Surgeons
Society Membership:
American Society of Clinical Oncology (ASCO): 1984
American College of Physicians (ACP), Member: 1981, Fellow: 1989
European Society for Medical Oncology (ESMO): 1997
American Society of Hematology (ASH): 1998
New York Medical Society / Michigan State Medical Society/American Medical Association/
SouthWest Oncology Group (Previously)
European Organization for the Research and Treatment of Cancer (EORTC) – Breast Cancer
Group: 2001
Lebanese Order of Physicians (LOP): 1985
Lebanese Cancer Society (LCS): 1995
Lebanese Society of Medical Oncology (LSMO): Founding President, 1997
Lebanese Society of Internal Medicine: President 2000-2003
Arab Medical Association Against Cancer (AMAAC)
3- Work Experience
1983 - 1985
Attending Physician
- The Long Island College Hospital, Brooklyn, New York 11201
- The Brooklyn Hospital, Brooklyn, New York 11201
- The Holy Family Hospital, Brooklyn, New York 11217
- The Methodist Hospital, Brooklyn, New York 11217
Assistant Clinical Professor of Medicine
- Long Island University Health Professions School, Brooklyn, New York
Clinical Instructor of Medicine
- State University of New York-Downstate Medical Center, Brooklyn, NY
1985 – 1989
Assistant Professor of Medicine
- King Saud University College of Medicine
Acting Head (1986 - 1988)
- Division of Hematology-Oncology, Department of Medicine
King Khalid University Hospital.
King Saud University College of Medicine, Riyadh, Saudi Arabia
1989 - 1993
Attending Physician
- Oakwood Hospital, 18101Oakwood Boulevard, Dearborn, MI 48123
- Grace Hospital, 6071 W. Outer Drive, Detroit, Michigan 48123
- Heritage Hospital, 24775 Haig, Taylor, MI 48180
- Annapolis Hospital, 33155 Annapolis Avenue, Wayne, MI 48184
Clinical Assistant Professor of Medicine
Wayne State University School of Medicine, Detroit, Michigan, USA
1993-Present:
American University of Beirut, Beirut, Lebanon
Clinical Assistant Professor: 1993
Clinical Associate Professor: 1998
Clinical Professor of Medicine: 2007
Professor of Clinical Medicine: 2010
Medical Licensures: - State of Maryland (License number: D25321)
- State of New York (License number: 147347)
- State of Michigan (License number: 47572)
- Lebanon (Order of Physicians number: 173/S)
B. RESEARCH and PUBLICATIONS:
1) PUBLICATIONS: Original Articles in Peer-Reviewed Journals.
(PubMed search: www. PubMed.gov/saghir n)
1. JCO/2015/617696: ASCO’s Efforts to Support Global Cancer Medicine
2.
Gabriel N Hortobagyi, Nagi S El-Saghir, Tanja Cufer, Eduardo Cazap, Roselle
de Guzman, Nicholas Anthony Othieno-Abinya, Jose Angel Sanchez, and Doug
Pyle (In press)
JGO/2015/000158: Global Practice and Efficiency of Multidisciplinary
Tumor Boards: Results of an ASCO International Survey
Nagi S El Saghir, Raghid N Charara, Firas Y Kreidieh, Vanessa Eaton, Kate
Litvin, Rania A Farhat, Katia E Khoury, Juliana Breidy, Hani Tamim, and Toufic
A Eid (In press)
3. Mayor S. WHO includes 16 new cancer drugs on list of essential medicines.
Lancet Oncol. 2015 May 21. pii: S1470-2045(15)70240-8. doi: 10.1016/S1470-
2045(15)70240-8. [Epub ahead of print]. Nagi El Saghir interviewed on
Trastuzumab: http://www.ncbi.nlm.nih.gov/pubmed/26004373
4. El Saghir NS, Zgheib NK, Assi HA, Khoury KE, Bidet Y, Jaber SM, Charara RN, Farhat
RA, Kreidieh FY, Decousus S, Romero P, Nemer GM, Salem Z, Shamseddine A, Tfayli
A, Abbas J, Jamali F, Seoud M, Armstrong DK, Bignon YJ, Uhrhammer N. BRCA1 and
BRCA2 Mutations in Ethnic Lebanese Arab Women With High Hereditary Risk Breast
Cancer. Oncologist. 2015 Apr;20(4):357-64. doi: 10.1634/theoncologist.2014-0364.
Epub 2015 Mar 16
5. Anderson BO, Ilbawi AM, El Saghir NS. Breast Cancer in Low and Middle
Income Countries (LMICs): A Shifting Tide in Global Health. Breast J. 2014 Nov
29. doi: 10.1111/tbj.12357. [Epub ahead of print]
6. El Saghir NS, Charara RN. International screening and early detection of breast
cancer: resource-sensitive, age- and risk-specific guidelines. Breast Cancer
Management, 2014, Vol. 3, No. 5, Pages 397-407 (doi: 10.2217/bmt.14.28).
7. El Saghir NS, Farhat R, Charara RN, Khoury KE. Enhancing cancer care in areas
of limited resources: Our next steps. Future Oncology, 2014 Oct;10(12):1953-65
8. Katia E. Khoury, Hussein A. Assi, Nagi S. EL Saghir, Cancer in Lebanon. In
Global Perspectives on Cancer: Incidence, Care and Experience. Kenneth D.
Miller, MD, and Miklos Simon, MD, Editors, Foreword by Sandra M. Swain.
Published by PRAEGER, Santa Barbara, California (In Press)
9. Cardoso F, Costa A, Norton L, Senkus E, Aapro M, André F, Barrios CH,
Bergh J, Biganzoli L, Blackwell KL, Cardoso MJ, Cufer T, El Saghir N,
Fallowfield L, Fenech D, Francis P, Gelmon K, Giordano SH, Gligorov J,
Goldhirsch A, Harbeck N, Houssami N, Hudis C, Kaufman B, Krop I,
Kyriakides S, Lin UN, Mayer M, Merjaver SD, Nordström EB, Pagani O,
Partridge A, Penault-Llorca F, Piccart MJ, Rugo H, Sledge G, Thomssen
C, Van't Veer L, Vorobiof D, Vrieling C, West N, Xu B, Winer E. ESOESMO 2nd international consensus guidelines for advanced breast cancer
(ABC2). Breast. 2014 Oct;23(5):489-502. doi: 10.1016/j.breast.2014.08.009.
Epub 2014 Sep 20.
10.
Cardoso F, Costa A, Norton L, Senkus E, Aapro M, André F, Barrios CH,
Bergh J, Biganzoli L, Blackwell KL, Cardoso MJ, Cufer T, El Saghir N,
Fallowfield L, Fenech D, Francis P, Gelmon K, Giordano SH, Gligorov J,
Goldhirsch A, Harbeck N, Houssami N, Hudis C, Kaufman B, Krop I,
Kyriakides S, Lin UN, Mayer M, Merjaver SD, Nordström EB, Pagani O,
Partridge A, Penault-Llorca F, Piccart MJ, Rugo H, Sledge G, Thomssen
C, Van't Veer L, Vorobiof D, Vrieling C, West N, Xu B, Winer E. ESOESMO 2nd international consensus guidelines for advanced breast cancer
(ABC2). Ann Oncol. 2014 Oct;25(10):1871-88. doi: 10.1093/annonc/mdu385.
Epub 2014 Sep
11. Nassar FJ, El Sabban M, Zgheib NK, Tfayli A, Boulos F, Jabbour M,
Saghir NS, Talhouk R, Bazarbachi A, Calin GA, Nasr R. miRNA as
Potential Biomarkers of Breast Cancer in the Lebanese Population and in
Young Women: A Pilot Study. PLoS One. 2014 Sep 18;9(9):e107566. doi:
10.1371/journal.pone.0107566. eCollection 2014.
12. El Saghir NS, Assi HA, Jaber SM, Khoury KE, Nachef Z, Mikdashi HF, ElAsmar NS, Eid TA. Outcome of Breast Cancer Patients Treated outside of
Clinical Trials. J Cancer. 2014 Jun 3;5(6):491-8. doi: 10.7150/jca.9216.
eCollection 2014
13. El Saghir NS, Keating NL, Carlson RW, Khoury KE, Fallowfield L. Tumor
boards: optimizing the structure and improving efficiency of multidisciplinary
management of patients with cancer worldwide. Am Soc Clin Oncol Educ Book.
2014:e461-6. doi:10.14694/EdBook_AM.2014.34.e461
14. Nagi El Saghir, Hussein Assi, Katia Khoury, Ahmad Elzawawy, Jaber Abbas,
and Toufic Eid. RE: Tumor boards and the quality of cancer care. Journal of The
National Cancer Institute. 2013 Dec 4;105(23):1839. doi:10.1093/jnci/djt312.
Epub2013Nov 1
15. Assi H, Ayoub Z, Jaber S, Sibai H, El Saghir N. Management of Paclitaxelinduced Hand-Foot-Syndrome. Breast Care. 2013;8:215-217.
DOI:10.1159/000352097
16. Ganz PA, Yip CH, Gralow JR, Distelhorst SR, Albain KS, Andersen BL,
Bevilacqua JL, de Azambuja E, El Saghir NS, Kaur R, McTiernan A, Partridge
AH, Rowland JH, Singh-Carlson S, Vargo MM, Thompson B, Anderson BO.
Supportive care after curative treatment for breast cancer (survivorship care):
Resource allocations in low- and middle-income countries. A Breast Health
Global Initiative 2013 consensus statement. Breast. 2013 Oct;22(5):606-15. doi:
10.1016/j.breast.2013.07.049. Epub 2013 Sep 3.
17. Assi HA, Khoury KE, Dbouk H, Khalil LE, Mouhieddine TH, El Saghir NS.
Epidemiology and prognosis of breast cancer in young women. J Thorac Dis 2013
May 25. DOI: 10.3978/ j.issn.2072-1439.2013.05.24.
18. Awada Z, Haider S, Tfayli A, Bazarbachi A, Saghir NE, Salem Z, Shamseddine
A, Taher A, Zgheib NK. Pharmacogenomics Variation in Drug Metabolizing
Enzymes and Transporters in Relation to Docetaxel Toxicity in Lebanese Breast
Cancer Patients: Paving the Way for OMICs in Low and Middle Income
Countries. OMICS. 2013 Jun 11. [Epub ahead of print]
19. El Saghir NS, Assi HA, Pyle D. ASCO's International Programs and How You
Can Become Involved. Am Soc Clin Oncol Educ Book. 2013;2013:405-10. doi:
E10.1200/EdBook_AM.2013.33.405.
20. Zgheib NK, Shamseddine AA, Geryess E, Tfayli A, Bazarbachi A, Salem Z,
Shamseddine A, Taher A, El-Saghir NS. Genetic polymorphisms of CYP2E1,
GST, and NAT2 enzymes are not associated with risk of breast cancer in a sample
of Lebanese women. Mutat Res. 2013 Apr 27. doi:pii: S0027-5107(13)00045-6.
10.1016/j.mrfmmm.2013.04.004. [Epub ahead of print]
21. El Saghir NS. Modern Cancer management and Research in the Middle East.
Lancet Oncol. 2012 Nov;13(11):1076-8. doi: 10.1016/S1470-2045(12)70479-5. Epub
2012 Oct 19
22. El Saghir NS, Anderson BO. Breast cancer early detection and resources: Where
in the world do we start? . Breast. 2012 Aug;21(4):423-5. Epub 2012 Jul 4
23. Cardoso F, Costa A, Norton L, Cameron D, Cufer T, Fallowfield L, Francis P,
Gligorov J, Kyriakides S, Lin N, Pagani O, Senkus E, Thomssen C, Aapro M,
Bergh J, Di Leo A, El Saghir N, Ganz PA, Gelmon K, Goldhirsch A, Harbeck N,
Houssami N, Hudis C, Kaufman B, Leadbeater M, Mayer M, Rodger A, Rugo H,
Sacchini V, Sledge G, Van't Veer L, Viale G, Krop I, Winer E. 1st International
consensus guidelines for advanced breast cancer (ABC 1). Breast. 2012
Jun;21(3):242-52. Epub 2012 Mar 16.
24. Tawil AN, Boulos FI, Chakhachiro ZI, Otrock ZK, Kandaharian L, El Saghir NS,
Abi Saad GS. Clinicopathologic and immunohistochemical characteristics of male
breast cancer: a single center experience. Breast J. 2012 Jan;18(1):65-8. Epub
2011 Oct 21.
25. El Saghir NS, Tfayli A, Hatoum H, Nachef Z, Dinh P, Awada A. Treatment of
metastatic breast cancer: State-of-the-art, subtypes and perspectives. Critical Reviews in
Oncology Hematology 2011 Dec;80(3):433-49 [Epub 2011 Feb 16].
26. Slamon D, Eiermann W, Robert N, Pienkowski T, Martin M, Press M, Mackey J, Glaspy
J, Chan A, Pawlicki M, Pinter T, Valero V, Liu MC, Sauter G, von Minckwitz G, Visco
F, Bee V, Buyse M, Bendahmane B, Tabah-Fisch I, Lindsay MA, Riva A, Crown J;
Breast Cancer International Research Group. Adjuvant trastuzumab in HER2-positive
breast cancer. N Engl J Med. 2011 Oct 6;365(14):1273-83 (BCIRG 005 and BCIRG 006
Investigator)
27. Anderson BO, Cazap E, El Saghir NS, Yip CH, Khaled HM, Otero IV, Adebamowo CA,
Badwe RA, Harford JB. Optimisation of breast cancer management in low-resource and
middle-resource countries: executive summary of the Breast Health Global Initiative
consensus, 2010. Lancet Oncol. 2011 Apr;12(4):387-98
28. El Saghir NS, Adebamowo, CA, Anderson, BO, Carlson RW, Bird PA, Corbex M,
Badwe RA, Bushnaq MA, Eniu A, Gralow JR, Harness JK, Masetti R, Perry F, Samiei
M, Thomas DB, Wiafe-Addai B, Cazap E. Breast cancer management in low resource
countries (LRCs): Consensus statement from the Breast Health Global Initiative. The
Breast 20 (2011) S3 - S11.
29. El Saghir NS, El-Asmar N, Hajj C, Eid E, Khatib S, Bounedjar A, Ajarim A,
Shamseddine A, Geara F, Jazieh A, Azim HA, Abdelkader Y, Kattan J, Abulkhair A.
Survey of utilization of multidisciplinary management tumor boards in Arab countries
The Breast 20 (2011) S70 - S74.
30. Tawil AN, Boulos FI, Chakhachiro ZI, Otrock ZK, Kandaharian L, El Saghir NS, Abi
Saad GS. Clinicopathologic and Immunohistochemical Characteristics of Male Breast
Cancer: A sSingle Center Experience. Breast J 2011 Oct 21 [Epub ahead of print]
31. Abulkhair A, Saghir N, Sedky L, Saadedin A, Elzahwary H, Siddiqui, N, Al Saleh N,
Geara F, Birido N, Al-Eissa N, Al Sukhun S, Abdulkareem H, Ayoub MM, Deirawan F,
Fayaz S, Kandil A, Khatib S, El-Mistiri M, Salem D, Sayd EH, Jaloudi M, Jahanzeb M,
Gradishar WI, Modification and Implementation of NCCN Guidelines™ on Breast
Cancer in the Middle East and North Africa Region. JNCCN 2010. Volume 8,
Supplement 1
32. El Saghir NS. Responding to the challenges of breast cancer in Egypt and other Arab
countries (Editorial). Journal Egyptian National Cancer Institute 2008: Vol. 20 No. 4:
309-312 (Published in 2010)
33. Abboud M, El-Saghir NS, Salame J, Geara FB. Complete response of HER2overexpressive breast cancer brain metastases with concurrent radiation therapy with
lapatinib and capecitabine. The Breast Journal.
34. Doumit MA, Huijer HA, Kelley JH, El Saghir N, Nassar N. Coping With Breast Cancer:
A Phenomenological Study. Cancer Nurs. 2010 March/April;33(2):E33-E39.
35. Charafeddine KM, Hatoum HA, Otrock ZK, Mahfouz RA, Salem ZM, Shamseddine AI,
Taher AT, El-Saghir NS, Bazarbachi A. Long-term outcome of adult acute
lymphoblastic leukemia in Lebanon: a single institution experience from the American
University of Beirut. Hematol Oncol Stem Cell Ther. 2009;2(2):333-9
36. Doumit MA, El Saghir N, Abu-Saad Huijer H, Kelley JH, Nassar N. Living with breast
cancer, a Lebanese experience. Eur J Oncol Nurs. 2009 Oct 6. [Epub ahead of print]
37. Adib S, El Saghir NS, Ammar W. Guidelines for Breast Cancer Screening in Lebanon.
Public Health Communication. J Med Liban 2009; 57 (2): 72-74.
http://lebanesemedicaljournal.org/articles/57-2/doc2.pdf
38. Hatoum HA, Jamali FR, El-Saghir NS, Musallam KM, Seoud M, Dimassi H, Abbas J,
Khalife M, Boulos FI, Tawil AN, Geara FB, Salem Z, Shamseddine AA, Al-Feghali K,
Shamseddine AI. Ratio Between Positive Lymph Nodes and Total Excised Axillary
Lymph Nodes as an Independent Prognostic Factor for Overall Survival in Patients with
Nonmetastatic Lymph Node-Positive Breast Cancer. Ann Surg Oncol. 2009 Aug 5. [Epub
ahead of print]
39. Musallam KM, Jamali FR, Hatoum HA, Seoud M, El-Saghir NS, Shamseddine AI.
Axillary Lymph Node Ratio Revisited. J Clin Oncol. 2009 Jul 20
40. Salim EI, Moore MA, Al-Lawati JA, Al-Sayyad J, Bazawir A, Bener A, Corbex M, ElSaghir N, Habib OS, Maziak W, Mokhtar HC, Seif-Eldrin IA, Sobue T. Cancer
epidemiology and control in the arab world - past, present and future. Asian Pac J Cancer
Prevention 2009 Jan-Mar; 10 (1): 3-16
41. El Saghir NS and Hatoum HA. Tailoring Treatment Decision-making in
Metastatic Breast Cancer. European Oncology 2008; Touch Briefings, Vol 2,
Issue 4: pp 43-46. http://www.touchoncology-eudigital.com/euoncology/200801/?pg=3&u1=texterity&cookies=1
42. Farhat MH, El Saghir NS, Shamseddine AI. Modified resistance to chemotherapy
and trastuzumab by bevacizumab in locally recurrent breast cancer. Breast, 2008
Nov 12. [Epub ahead of print]
43. El Saghir NS, Eniu A, Carlson RW, Aziz Z, Vorobiof D, Hortobagyi GN for the
Breast Health Global Initiative (BHGI) Systemic Therapy Focus Group. Locally
advanced breast cancer: treatment guidelines with particular attention to low- and
middle-income countries. Cancer. 2008;113(8 suppl):2314-2323
44. Eniu A, Carlson RW, El Saghir NS, Bines J, Bese N, Vorobiof D, Anderson BO
on behalf of the Breast Health Global Initiative. Guideline implementation for
breast healthcare in low- and middle income countries: treatment resource
allocation. Cancer. 2008;113(8 suppl):2268-2280
45. Farhat MH, El-Saghir NS, Shamseddine AI. Hand-foot syndrome with docetaxel:
a five-case series. Ann Saudi Med. 2008 Sep-Oct;28(5):374-7.
46. El-Saghir NS, Khalil M, Eid T, El Kinge AR, Charafeddine M, Geara F, Seoud
M, Shamseddine A. Trends in epidemiology and management of breast cancer in
developing Arab countries: a literature and registry analysis. Int J Surg. 2007
Aug;5(4):225-33. Epub 2006 Aug 24.
47. Geara F, Nasr E, Tucker S, Bikhazi K, Abbas J, Salem Z, Shamseddine A, Issa P,
El Saghir N. Breast cancer patients with 10 or more involved axillary lymph
nodes treated by multimodality therapy: Influence of clinical presentation on
outcome. International Journal of Radiation Oncology, Biology, Physics Int J
Radiat Oncol Biol Phys. 2007 Feb 24; [Epub ahead of print]
48. El-Saghir NS,.El-Hajj II,Makarem JA, Otrock ZK. Combined ovarian ablation
and aromatase inhibition as first line therapy for hormone receptor-positive
metastatic breast cancer in premenopausal women: report of three cases.
Anticancer Drugs. 2006 Sep;17(8):999-1002.
49. El Saghir NS, Seoud M, Khalil MK, Charafeddine M, Salem ZK, Geara FB,
Shamseddine AI. Effects of young age at presentation on survival in breast
cancer. BMC Cancer. 2006 Jul 20;6(1):194 [Epub ahead of print]
50. Shamseddine AI, Otrock ZK, Khalifeh MJ, Yassine HR, Charafeddine M, AbdelKhalek Z, Chehal A, Bitar N, Jalloul R, Dheiny M, Dandashi A, Wehbeh M, ElSaghir NS. A clinical phase II study of a non-anthracycline sequential
combination of Cisplatin-Vinorelbine followed by Docetaxel as first line
treatment in metastatic breast cancer. Oncology 2006;70:330-338
51. El-Zahabi LMN, Jamali FR, El-Hajj II, Naja MO, Salem Z, Shamseddine A, El
Saghir NS, Zaatari G, Geara F, Soweid AM. The value of EUS in predicting the
response of gastric MALT lymphoma to Helicobacter Pylori eradication
Gastrointest Endosc. 2007 Jan;65(1):89-96.
52. de Castro Junior G, Puglisi F, de Azambuja E, El Saghir NS, Awada A.
Angiogenesis and cancer: A cross-talk between basic science and clinical trials
(the "do ut des" paradigm). Crit Rev Oncol Hematol. 2006 Jul;59(1):40-50. Epub
2006 Apr 4. Review.
53. Shamseddine A, El-Saghir N, Chehal A, Saliba T, Taher A. Cisplatin and
vinorelbine (PVn) for the treatment of advanced breast cancer: 10 years of
experience. J Med Liban. 2004 Jul-Sep;52(3):126-30. PMID: 16432968 [PubMed
- in process]
54. Otrock ZK, Hourani MH, Oghlakian GO, Nasrallah AT, El-Saghir NS. Renal cell
carcinoma presenting as an isolated neck mass. Clin Oncol (R Coll Radiol). 2005
Dec;17(8):665-6
55. El Saghir NS, Otrock ZK, Bleik JH. Anterior unilateral uveitis complicating
zoledronic acid therapy. BMC Cancer BMC Cancer. 2005 Dec 6;5(1):156 [Epub
ahead of print].
56. El Saghir N, El-Hajj I, Geara F, Hourani M. Trauma-associated growth of
suspected dormant micrometatasis. BMC Cancer 2005 Aug 4;5(1):94.
57. El-Saghir NS, Otrock Z, Bizri AR, Uwayda M, Oghlakian G. Erysipelas
infections after loco-regional therapy for breast cancer. Breast. 2005
Oct;14(5):347-51. Epub 2005 Jun 28 Jun 27.
58. Choueiri MB, Otrock ZK, Tawil AN, El-Hajj I, El Saghir N. Inflammatory breast
cancer in a male. New Zealand Med J. 2005 Jul 15; 118(1218):U1566.
59. El Saghir, Shamseddine AI, Geara F, Bikhazi K, Rahal B, Salem ZMK, Taher A,
Tawil A, El Khatib Z, Abbas J, Ali Khalil. Hourani M, Seoud M. Breast Cancer in
Lebanon: Increased percentages and age adjusted incidence rates in younger-aged
groups at presentation: Implications for screening and for Arab-American ethnic
groups . Ethnicity and Disease: Ethnicity and Disease, 2005 Winter; Vol 15(1
Suppl 1):S1-11-S1-12: p 1-10.
60. El Saghir NS. An Update on Recent Cancer Trends in Lebanon. Ethnicity
and Disease, 2005 Winter Vol 15, Suppl. 1, S II p 11-17.
61. El-Hajj I, Chehal A, El Saghir N. Recurrent GI bleeding and surgery following
initial response to imatinib therapy in GIST of the stomach. Digestive Diseases
and Sciences 2005 Jan;50(1):65-9.
62. Geara F, Nasr E, Tucker SL, Brihi E, Zaytoun G, Hadi U, Salem Z, El Saghir N,
Issa P, Shamseddine A. Nasopharyngeal Cancer in the Middle East: Experience of
The American University of Beirut Medical Center. International Journal
Radiation Oncology Biology Physics 2005 Apr 1;61(5):1408-15.
63. El Saghir NS. Screening for Breast Cancer in the Middle East (Editorial). British
Medical Journal – Middle East 2004; 11: 6-8.
64. El Saghir NS, Otrock ZK, Mufarrij AA, Abou Mourad Y, Salem Z, Shamseddine
AI, Abbas J. Dexrazoxane for anthracycline extravasation and GM-CSF for
delayed skin ulceration and wound healing. Lancet Oncology 2004; 5 (5): 320321
65. El Saghir NS and Otrock ZK Docetaxel extravasation into the normal breast
during breast cancer treatment. Anti-Cancer Drugs 2004; 15 (4): 401-404.
66. Shamseddine AI, Sibai AM, Geahchan N, Rahhal B, El Saghir N, Ghosn M,
Aftimos G, Chamseddine N, Seoud M. for The Lebanese Cancer Epidemiology
Group. Cancer incidence in postwar Lebanon: findings from the first national
population-based registry, 1998. Annals of Epidemiology 2004 Oct;14(9):663-8.
67. Shamseddine A, Saliba T, Aoun E, Chehal A, Saghir N, Salem Z, Bazarbachi A,
Khalil M, Taher A. Thrombotic Thrombocytopenic Purpura: 24 years of
experience at the American University of Beirut Medical Canter. Journal of
Clinical Apheresis 2004; 19(3):119-124
68. Shamseddine AI, Chehal A, Usta I, Taher A, Salem Z, El-Saghir N, Taher A.
Thrombotic Thrombocytopenic Purpura in Pregnancy, report of 4 cases and
review of the literature. Journal of Clinical Apheresis 2004; 19 (1): 5-10.
69. El Saghir, Shamseddine AI, Geara F, Bikhazi K, Rahal B, Salem ZMK, Taher A,
Tawil A, El Khatib Z, Abbas J, Hourani M, Seoud M. Age Distribution of Breast
Cancer in Lebanon: Increased Percentages and Age Adjusted Incidence Rates in
Younger-Aged Groups at Presentation. Leb Med J 2002; 50 (1-2): 3-9.
70. Seoud M, El-Saghir N, Salem Z, Shamseddine Awwad J, Mudawwar W, Khalil
A. Tamoxifen and Ovarian Cysts: A prospective study. Eur J Obstet Gynecol
Reprod Biol. Dec 2001; 101: 77-80.
71. Mansour AM, Salti HI, Han DP, Khoury A, Friedman SM, Salem Z, Ibrahim K,
Bazerbachi A, Saghir N. Ocular findings in aplastic anemia. Ophtalmologica
2000; 214 (6): 399-402.
72. Seoud M, Shamseddine AI, Khalil A, Salem Z, Saghir N, Bikhazi K, Bitar N,
Azar G, Kaspar H. Tamoxifen and endometrial pathologies: A prospective study.
Breast Diseases: Year Book Quarterly, June 2000. (Abstracted from Gynecologic
Oncology; 1999: 75: 15-19).
73. Seoud M, Shamseddine AI, Khalil A, Salem Z, Saghir N, Bikhazi K, Bitar N,
Azar G, Kaspar H. Tamoxifen and endometrial pathologies: A prospective study.
Gynecologic Oncology; 1999: 75: 15-19.
74. Taher A, Shamseddine A, Saghir N, Seoud M, Mourad F, Dabajah B, Khalil A.
Acquired protein C deficiency following Cisplatinum-Navelbine administration
for locally advanced breast cancer: Case report. European Journal
Gyneacological Oncology 1999; 4: 323-324.
75. Shamseddine AI, Taher A, Dabaja B, Dandashi A, Salem Z, El Saghir NS.
Combination chemotherapy with cisplatinum-vinorelbine for relapsed and
chemotherapy pretreated metastatic breast cancer. American Journal of Clinical
Oncology (Cancer Clinical Trials) 1999; 22(5): 298-302.
76. El Saghir NS, Adib S, Mufarrij A, Taher A, Kahwaji S, Issa P, Shamseddine AI.
Cancer in Lebanon: Analysis of 10220 cases from the American University of
Beirut Medical Center. Lebanese Medical Journal 1998; 46: 4-11.
77. Shamseddine A, Khalil A, Abi-Nasr T, Kibbi AG. Seoud M, El Saghir NS.
Granulocyte Macrophage-Colony Stimulating Factor for the treatment of
chemotherapy-induced cutaneous ulcers. European Journal of Gynecological
Oncology 1998.
78. Adib S, Mufarrij A, Adib S, Shamseddine A, Kahwaji S, Issa Ph, El Saghir NS.
Cancer in Lebanon: Tumor Registry at the American University of Beirut 19831994. Annals of Epidemiology 1998; 8: 46-51.
79. El Saghir NS, Bizri AR, Salem NS, Hussami T, Salem Z, Shamseddine AI.
Pressure Ulcer Accelerated Wound Healing with Local Injections of Granulocyte
Macrophage-Colony Stimulating Factor. Journal of Infection, 1997: 35: 179-182.
80. Saghir NS, Salem Z, Adib S, Bikhazi K, Issa Ph. Breast Cancer Screening:
Recommendations and Controversies, with reference to Screening in Lebanon.
Lebanese Medical Journal 1997; 45: 206-211.
81. El Saghir NS. Combination chemotherapy with tetracycline and aggressive
supportive care for immunoproliferative small-intestinal disease lymphoma.
Journal of Clinical Oncology 1995; 13: 794 (Letter).
82. Saghir NS. Breast cancer: Guidelines for modern management. Lebanese
Medical Journal 1994; 42: 17-22
83. Kyriacou C, Loewen RD, Gibbon K, Hafeez M, Stuart AE, Whorten G, Al-Faleh
FZ, Al-Mofleh I, Jessen K, Mass RE, El Saghir NS, Al-Khudairy N, Rifai MM,
Qteishat W. Pathology and clinical features of Gastro-intestinal lymphoma in
Saudi Arabia. Scottish Medical Journal 1991; 36: 68 - 74.
84. Ajarim DS, Santhosh-Kumar CR, Higgy KE, El Saghir NS, Al-Momen AK,
Shipkey F. Granulocytic Sarcoma of the thymus in acute promyelocytic
leukemia. Clinical & Laboratory Haematology (UK) 1990; 12: 97 - 99.
85. El Saghir NS, Jessen K, Al-Mofleh I, et at. Primary gastrointestinal lymphoma in
the Middle East: analysis of 23 cases from Riyadh, Saudi Arabia. Saudi Medical
Journal 1990; 11: 95 - 98.
86. Zeitany RG, El Saghir NS, Santosh-Kumar CR, Sigmon MA. Increased
aminoglycoside dosage requirements in patients with hematologic malignancy.
Antimicrobial Agents and Chemotherapy 1990: 34: 702 - 708.
87. El Saghir NS, Al-Hedaithy SSA, Hawass N, Fawzy E, Hall AD. Pulmonary
aspergillosis due to Aspergillus Terreus var. Africanus in acute leukemia. Annals
of Saudi Medicine 1989; 9: 497 - 501.
88. El Saghir NS, Ajarim DS, Hall AD, et al. Adult acute nonlymphocytic leukemia
in Saudi Arabia. Annals of Saudi Medicine 1989; 9: 158-164.
89. Santosh-Kumar CR, Al-Hedaithy SSA, El Saghir NS, Ajarim DS. Cavitating
pneumonia due to Trichosporon Beigelii in a patient with acute myeloid leukemia.
Journal of Infection (UK) 1989: 19: 65-68.
90. Jamjoom ZB, El Saghir NS, Sadiq S, Malabary T, Al-Khudairy N. Direct spread
of medullobastoma in adjacent extrameningeal tissues. Acta Neurochirurgica
1989; 97: 171 - 176.
91. El Saghir NS, Hall AD, Santhosh-Kumar CR, Zeitany RG. Infectious
complications during therapy of acute leukemia in Saudi Arabia. Journal of
Hospital Infection (UK) 1989; 14: 209 - 215.
92. El Saghir NS, Jessen K, Mass RE, et al. Combination chemotherapy for primary
small intestinal lymphoma in the Middle East. European Journal of Cancer &
Clinical Oncology 1989; 25: 851 - 856
93. El Saghir NS, Geltman RL. Treatment of acquired amegakaryocytic
thrombocytopenic purpura with cyclophosphamide. American Journal of
Medicine 1986; 81: 139-142.
94. El Saghir NS, Hawkins KA. Hepatotoxicity following vincristine therapy.
Cancer 1984; 54: 2006-2008.
2) Books:
1. Nagi Saghir, MD. ABC of Breast Diseases: From Prevention to Treatment.
Arab Scientific Publishers 2005, Beirut, Lebanon; 2nd Edition: 2006;
New Fully Updated Revised Edition: 3rd Edition 2013.
Reviewed in: An-nahar Daily Newspaper, December 6, 2004 (By Rola Muawad); Diyar Daily Newspaper,
December 7, 2004 (By Suzanne Birbari); Future Television: Book of the WEEK (January 2005); Al-Hayat Pan arab
daily newspaper, February 2005 (By Dr M Moghrabi); NBN Satellite Television: Morning Show and Book
Reviews; LBC Satellite TV: Tea Time Show, February 2005; ANB Satellite TV. Morning Show. March 2005;
Assafir daily newspaper. April 2005 (by Madonna Semann); AUBulletin Today. AUB Publications, March 2005-0602; NTV Special Health Program with Dr. Evelyne Aoun, April 2005 (x2); MainGate: AUB Quarterly Magazine,
April-June 2005; Radio Lebanon: 2 sessions, June 16 and 18, 2005; Asharq-al-Awsat, March 2006; CancerWorld
(Magazine of the European School of Oncology): Jan 2006.
2. Nagi El Saghir: Knowledge Road map to Cure (In English and in Arabic
languages): Public Awareness Booklet written for and Published and distributed
by Lebanese Breast Cancer Foundation LBCF and Lebanese Ministry of Health.
Anis Printing 2011, Updated in 2014, Beirut, Lebanon
3) Book Chapters:
1. Katia E. Khoury, Hussein A. Assi, Nagi S. El Saghir, Cancers by Country
and Region: Lebanon. In Global Perspectives on Cancer (2 Volumes):
Incidence, Care and Experience. Kenneth D. Miller, MD, and Miklos
Simon, MD, Authors and Editors, Foreword by Sandra M. Swain. Published
by PRAEGER, ABC-CLIO, LLC, Santa Barbara, California, pp 391-404.
http://www.amazon.ca/Global-Perspectives-Cancer-volumesExperience/dp/1440828571#reader_1440828571
2. UICC Review of the World Health
Organization’s Model List of Essential
Medicines for cancer. Lawrence Shulman
and Julie Torode (Editors), Nagi El Saghir
(Contributor to Chapter on Metastatic
Breast Cancer). Released May 2015:
http://www.who.int/selection_medicines/co
mmittees/expert/20/applications/cancer/en/
3. Handbook Cancer Prevention and Management, (Chapter on Breast Cancer:
Nagi El Saghir and Omalkhair Abulkhair). AR Jazieh & O. Abulkhair, Editors.
2010, Riyadh, Saudi Arabia.
4. Handbook Cancer Prevention and Management, (Co-author of Chapter on
Improving Cancer Care in the Arab World: Chapter on Tobacco Control. AR
Jazieh & O. Abulkhair, Editors. 2010, Riyadh, Saudi Arabia
5. Ali Shamseddine, Editor, Nagi Saghir, Major Contributor. AUB Tumor Registry:
20 years of service, www.aub.edu.lb/`webhcc/tumorregbook.htm, April 2004
6. Gader AMA, Al-Momen AK, Khudairy N, El Saghir NS, et al. Guidelines to
blood transfusion therapy (Booklet). King Saud University, Riyadh, Saudi
Arabia. 1988
4) Editor, Proceedings & Highlights:
1. MEMA 2006 Middle East Medical Assembly (Including LSMO-6 Lebanese
Society of Medical Oncology 6th Annual Meeting) Abstracts and Presentations
Book, Ghassan Hemadeh, Nagi El Saghir, Editors: 40th MEMA, May 11-14,
2006.
2. MEMA 2005 Middle East Medical Assembly Abstracts and Presentations
Book, Nagi El Saghir, Chairman, Publications Committee, Aghiad
Koutubi, Chairman, Scientific Committee, Ghassan Hamadeh, Chairman.
39th MEMA, May 12-15, 2005.
3. Nagi El Saghir, Editor-in-Chief. Educational Book & Proceedings. Arab
International Cancer Congress AICC 2001. Arab Medical Association
Against Cancer. Beirut, Lebanon, September 6-9, 2001.
4. Nagi El Saghir, MD, Editor, Proceedings of the 3nd Annual Cancer
Congress 2000: LSMO-3, Supplement, Lebanese Medical Journal, July
2001.
5. Nagi El Saghir, MD, Editor, Proceedings of the 2nd Annual Cancer
Congress LSMO-2, Supplement, Lebanese Medical Journal, January 2000.
6. Nabil Chamseddine, Nagi El Saghir, Marwane Ghosn, Editors.
Educational and Abstract Book. Third Pan Arab Cancer Congress. PACC
3. Arab Council Against Cancer. April 2000.
7. Nagi El Saghir. Editor, Proceedings of the 1st Annual Cancer Congress of
the Lebanese Society of Medical Oncology. LSMO-1. Lebanese Medical
Journal 1999; 47 (6): 367-371.
8. Cardoso F, El Saghir NS, Bernard-Marty C, Piccart M. The Future of
Systemic Breast Cancer Therapy. Indian Oncology Society Textbook.
Elsevier Medical Science Publishers, USA.
9. Nagi Saghir, MD. Breast cancer in Lebanon: Recent Trends and Future
Directions. Review, Proceedings of the Lebanese Society of Medical
Oncology Annul Meeting: National Forum LSMO-5, November 18-20,
2004, Beirut, Lebanon
10. Ludwig H, Bartelink H, El-Saghir N, Jassem J, Khaled H, Tonato M.
International Panel Highlights (Europe) of the 40th Annual Meeting of the
American Society of Clinical Oncology. New Orleans, LA, June 8, 2004.
www.asco.org/ international panel discussion/Europe
2) Peer –Reviewer for Medical Journals, including:
The Breast, Lebanese Medical Journal, Cancer Chemotherapy and Pharmacology, Future
Oncology, International Journal of Surgery, Expert Opinion Investigational Drugs, Acta
Oncologica, Annals of Oncology, World Journal of Surgical Oncology, The Oncologist, Lancet
Oncology, JNCI, UICC.
C) Select ASCO Connection articles By Nagi S. El Saghir:
1. ASCO Connection September 2015, by Nagi El Saghir: Best of ASCO: An
Annual International Tradition https://connection.asco.org/magazine/ascointernational/best-asco-annual-international-tradition
2. ASCO Daily News 2015 Annual Meeting: a Global Look at Drug Approval by
Nagi El Saghir and Firas Kreidieh: https://am.asco.org/examining-drug-approvalprocess-lebanon-egypt-algeria-and-gulf-arab-countries#.VXa1_vU6qvo.mailto
3. ASCO Daily News 2015 Annual Meeting: Developing Resource-Stratified
Guidelines by Gilberto Lopes, Alexandru Eniu, Nagi El Saghir:
https://am.asco.org/developing-resource-stratified-guidelines-oncology-improvecancer-care-worldwide#.VXa2MzzgObk.mailto
4. ASCO Connection Interviews: Members behind the Scenes – November 2014
issue:
http://connection.asco.org/Magazine/Article/id/4058/Dr-Nagi-S-El-SaghirDancing-to-His-OwnRhythm/et_cid/34805168/et_rid/463479491/linkid/El+Saghir.aspx
5. ASCO Connection July 2014, by Nagi S. El Saghir:
http://connection.asco.org/Commentary/Article/id/3941/Efficient-Teamwork-atTumor-Boards.aspx
6. ASCO Connection June 2014, By Nagi S. El Saghir:
http://connection.asco.org/Commentary/Article/id/3877/50-Years-of-Progress-50Years-of-ASCO-Grassroots-to-Global.aspx
7. ASCO Connection, Member News, June 2014: Dr. Nagi El Saghir Awarded
Lebanon’s Top Honor | ASCO Connection Advertisement Login Committee.... 23
Jun 2014. The award recognized Dr. El Saghir’s work in breast cancer research
and community health awareness.
http://connection.asco.org/Magazine/Article/id/3922/Dr-Nagi-El-Saghir...
8. 2013 Best of ASCO - Lebanon: Timely Oncology Updates and Celebrations in the
Middle East Despite War and Turmoil 23 Jul 2013 2:42 PM By Nagi S. El
Saghir, MD; Khaled M. Ibrahim, MD; and Georges Chahine... El Saghir with an
“Outstanding Excellence Award,” and a presentation on the ASCO International
Affairs Committee portfolio and activities by Dr. El Saghir.
9. Letter from The Chair: December 2013:
http://connection.asco.org/Commentary/Article/id/3723/Letter-from-the-InternationalAffairs-Committee-Chair-Oncologists-for-Science-and-Peace.aspx
10. ASCO Connection: Best of ASCO 2010:
http://connection.asco.org/Magazine/Article/id/2807/Participants-Laud-aSuccessful-Best-of-ASCO-Lebanon-2010.aspx
11. ASCO Connection, March 2013, By Sandra Awain, MD:
http://connection.asco.org/Forums/forumid/6/threadid/440/scope/posts.aspx
https://connection.asco.org/Commentary/Article/id/3487/Bridging-Inequities-to-BringHope-to-Patients-Worldwide.aspx
12. ASCO Connection on October Campaigns in Lebanon:
http://connection.asco.org/Magazine/Article/id/3373/Lebanon-Lights-Up-in-Pink-its-Landmark-Raouch%C3%A9-Rocks-in-the-Middle-of-the-MediterraneanSea.aspx
13. ASCO Connection October 2013 Cover Story:
http://connection.asco.org/Magazine/Article/id/3688/Oncology-withoutBorders.aspx
14. World Cancer Day, February 2014, by Nagi EL Saghir:
https://connection.asco.org/Commentary/Article/id/3774/World-Cancer-Day2014-Debunk-the-Myths.aspx
15. ASCO Connection July 2013:
http://connection.asco.org/Magazine/Article/ID/3606/2013-Best-of-ASCO-Lebanon-Timely-Oncology-Updates-and-Celebrations-in-the-Middle-EastDespite-Political-Instabilities-and-Turmoil.aspx
16. The ASCO POST: September 1, 2012:
http://www.ascopost.com/issues/september-1-2012/despite-challenges,-initiativesbring-gradual-improvements-to-cancer-care-in-lebanon.aspx
17. ASCO Connection online exclusives November 2012:
http://connection.asco.org/Magazine/Article/ID/3373/Lebanon-Lights-Up-inPink-its-Landmark-Raouche-Rocks-in-the-Middle-of-the-Mediterranean-Sea.aspx
18. El-Saghir N: ASCO Foundation International Travel Grants Program: A mentor’s
perspective. ASCO News July 2004.
http://www.asco.org/asco/downloads/asconews_july04.pdf
19. Nagi El Saghir. Breast Cancer in Lebanon and Worldwide: A global health
priority. ASCO News Quarterly Magazine. April-June 2003.
http://www.asco.org/asco/downloads/apr_news03.pdf.
D) Invited Speaker/ Grand Rounds / International conferences
1. Recent Advances in Overall Management of patients with breast cancer. AUB
BCC3 American University of Beirut 3rd Annual Breast Cancer Conference.
Beirut, Lebanon. February 13-14, 2015.
2. Breast Cancer Screening Update and Impact of Campaigns in Lebanon. AUB
BCC3, Beirut, Lebanon, February 13-14, 2015
3. Resource-adapted guidelines for Breast Cancer Management. 5th International
Congress of Breast Disease Centers, Antwerp, Belgium, February 5-7, 2015
4. Adjuvant chemo/hormonal therapy in HER2-negative Early Breast Cancer:
Evidence based options for Node-negative and Node-positive disease. Dubai
Breast Cancer Master Class 2014, Dubai, United Arab Emirates, December 19-20,
2014.
5. ABC of Breast Cancer 2014. Medical Grand Rounds, CME department, Oakwood
Hospital and Medical Center, Dearborn, Michigan, USA, December 16, 2014
6. ABC Guidelines for management of Advanced Breast Cancer 2014. Patient
Management Conference, Breast Cancer program, Barbara Ann Karmanos Cancer
Institute, Wayne State University, Detroit, Michigan, USA, December 15, 2014
7. El Saghir, et al. BRCA1 and BRCA2 mutations in Lebanese breast Cancer. Poster
Presented at San Antonio Breast Cancer Symposium, December 9-13, 2014.(See
Above)
8. Advanced Breast Cancer Guidelines updates. 3rd Emirates Oncology Conference.
Emirates Palace, Abu Dhabi, United Arab Emirates. November 13-15, 2014
9. Hormonal Therapy for Metastatic Breast Cancer. AUB Oncology Nursing and
Development. AUBMC, November 11, 2014
10. Panel / Case Discussions: ASCO/ESMO 2014 Updates. UAE Cancer Congress.
October 30-Nov 1, 2014, Dubai, United Arab Emirates.
11. Advanced Breast Cancer Guidelines ABC2 Updates. UAE Cancer Congress.
October 30-Nov 1, 2014, Dubai, United Arab Emirates.
12. Case Discussions – Nagi S. El Saghir and Hope Rugo: Breast Cancer HR+,
HER2+ Breast Cancer. Oncology Leaders Summit (OLS) annual meeting,
October 26-28, 2014, Barcelona, Spain
13. Assembling the Multidisciplinary Team. Nagi El Saghir, Guy Jerusalem, Evi
Papadopoulos, Constantinos Papazisis and Matti Aapro: October 26-28, Oncology
Leaders Summit, OLS annual meeting, Barcelona, Spain.
14. ABC2 Guidelines. International Jordan Oncology Meeting. Amman, Jordan,
October 18, 2014
15. Emerging New Paradigms in Breast Cancer Screening. Medical Grand Rounds,
Department of Internal Medicine, American University of Beirut Medical Center,
October 7, 2014.
16. ASCO Tumor Boards Survey. Poster at ESMO, Madrid, Spain. September 2015.
17. Nagi El Saghir. Best of ASCO Breast cancer ALTTO adjuvant trial, and Best of
ASCO Breast Cancer meta-analysis of adjuvant trastuzumab trials in small
tumors. Best of ASCO Lebanon, June 2-21, 2014, Beirut, Lebanon.
18. Nagi El Saghir. ASCO Annual Meeting Educational Sessions: Effect of Tumor
Boards on the Diagnosis and Treatment of Patients with Cancer: International
Perspectives. ASCO Annual Meeting, May 30-June 3, 2014, Chicago, IL
19. Nagi El Saghir. Guidelines for treatment of Advanced Breast Cancer. LSMO 9:
Lebanese Society of Medical Oncology 9th Annual Meeting. April 26, 2014.
20. Nagi El Saghir. Tumor Boards Discussions: Breast cancer cases. LSMO 9:
Lebanese Society of Medical Oncology 9th Annual Meeting.
21. Nagi S. El Saghir: Breast Cancer Update Course – European School of
Oncology. Milano, Italy: Application of new data to low income countries (when
resources are limited), BHGI guidelines. May 3-4, 2014.
22. Nagi S. El Saghir: Breast Cancer Update Course – European School of
Oncology. Milano, Italy: Tumor Board Panel Case Discussions. May 3-4, 2014.
23. Nagi El Saghir. Overview of diagnosis and management of patients with breast
cancer. AUBMC BCC2 Annual Breast Cancer Conference. Beirut, Lebanon,
February 14-15, 2014
24. Debate: Patients‘ rights and patient advocacy in Lebanon. AUBMC BCC2:
With Moderator: Ms. Rola Mouawad and Panel: Ms. Loryne Atoui, Ms.
Fatme Baydoun, Ms. Rima Dandashi, Dr. Myrna Doumit, Ms. Anne
Franjieh, Ms. Mirna Hoballah, Ms. Azza Mroue, Ms. Rima Wehbe, Dr.
Michel Saade, Ms. Helen Nuwayhid and Dr. Nagi El Saghir.
25. Nagi El Saghir. New ABC2 guidelines for locally advanced breast cancer.
AUBMC BCC2: Second Annual AUBMC Breast Cancer Conference. Beirut,
Lebanon, February 14-15, 2014
26. Breast Cancer Tumor Boards Case Discussion Panels with Mahmoud ElTamer,
Nagi Khouri, Alphonse Taghian, Fady Geara, Marwan Ghosn, Georges Aftimos,
Jaber Abbas, Elie Nasr, Faek Jamali, PierFranco Conte and Nagi El Saghir:
AUBMC BCC2: Second Annual AUBMC Breast Cancer Conference. Beirut,
Lebanon, February 14-15, 2014
27. Nagi El Saghir. International Guidelines for Breast Cancer: Metastatic Breast
Cancer ABC2 Guidelines. BGICC Breast Gyn International Cancer Conference,
Cairo, Egypt, January 9-10, 2014
28. Nagi El Saghir. Guidelines for Breast Cancer in Young Women. Member of
Panel at BGICC Breast Gyn International Cancer Conference, Cairo, Egypt,
January 9-10, 2014
29. Nagi El Saghir. Role of Neoadjuvant TX (hormonal and chemo) in maximizing
oncoplastic results. Emirates Oncology Conference, EOC – Breast and
Gynecological Oncology Cancer Society session, Abu Dhabi, United Arab
Emirates, Nov 14-16, 2013
30. Nagi El Saghir. Disparities in access to supportive /palliative specialized care.
Supportive and Palliative Care Issues. Advanced Breast Cancer ABC2 Consensus
Conference, Lisbon, Portugal, Nov 7-9, 2013.
31. Nagi El Saghir. New Trends in the Survival of patients with Locally Advanced
Breast Cancer. Poster S45 (Nagi El Saghir, Hussein Assi, Zahi Nachef, Hana
Mikdashi, Nadine El Asmar, Katia Khoury). ABC2, Lisbon, Portugal Nov 7-9,
2013
32. Nagi El Saghir. Recent Advances in Breast Cancer Management. American
Lebanese Medical Association (ALMA) Annual meeting. Universite Saint Esprit
Kaslik (USEK), Kaslik, Lebanon, June 27-28, 2013.
33. Nagi El Saghir. Diagnosis, subtypes, work-up, and upfront management of the
patient with breast cancer. Memorial Sloan Kettering Cancer Center – American
University of Beirut Medical Center (MSKCC-AUBMC) Oncology Course, June
24-28, 2013, AUB, Beirut, Lebanon.
34. Nagi El Saghir. Locally advanced breast cancer. Memorial Sloan Kettering
Cancer Center – American University of Beirut Medical Center (MSKCCAUBMC) Oncology Course, June 24-28, 2013, AUB, Beirut, Lebanon
35. Nagi El Saghir. Adjuvant chemotherapy breast cancer. Best of ASCO, June 2122,2013, Beirut, Lebanon
36. Nagi El Saghir. Adjuvant tamoxifen in early breast cancer. Best of ASCO 2013,
June 21-22, 2013, Beirut, Lebanon.
37. Nagi El Saghir. ASCO’s International Programs and How You Can Become
Involved. Educational Session: Global Initiatives to Enhance Cancer Care in Areas of
Limited Resources: What ASCO Members Are Doing and How You Can Become Involved.
American Society of Clinical Oncology Annual Meeting, May 31-June4, 2013, Chicago, Illinois, USA
38. Nagi El Saghir. Update on breast cancer control and management in Lebanon
and Arab Countries. Notre Dame University School of Nursing and Health
professions, May 14-15, 2013, NDU – Louize, Lebanon
39. Nagi El Saghir. Role of Bone-Modifying Agents in Metastatic Breast Cancer.
Pan Arab Cancer Congress PACC-13, April 26-27, 2013, Amman, Jordan
40. Nagi El Saghir. Latest advances in adjuvant hormonal therapy. American
University of Beirut Breast Cancer Conference-1, February 8-9, 2013, Beirut,
Lebanon.
41. Nagi El Saghir. Pathological Complete Remission and Survival in Neo-Adjuvant
Therapy. American University of Beirut Breast Cancer Conference-1, Beirut,
Lebanon.
42. Nagi El Saghir. Recent Advances in neo-adjuvant therapy for breast cancer.
American University of Beirut Breast Cancer Conference-1, Beirut, Lebanon.
43. Nagi El Saghir. Guidelines for treatment of metastatic breast cancer. Emirates
Oncology Conference. Abou Dhabi, UAE, November 8, 2012.
44. Nagi El Saghir. Incorporating bisphosphonates among women with early stage
breast cancer, Debates and Controversies, PRO: Nagi El Saghir, CON: Sudeep
Gupta. UAE Cancer Congress, Dubai, October 12-13, 2012.
45. Nagi El Saghir. Adjuvant Tam-AI versus Upfront AI hormonal therapy in postmenopausal women: Debates and Controversies. Upfront AI: Ana-Maria
Gonzalez, Tamoxifen followed by AI: Nagi El Saghir. UAE Cancer Congress,
Dubai, October 12-13, 2012.
46. Nagi El Saghir. Breast Health Global Initiative: BHGI – IAEA Summit,
Survivorship Panel, Vienna, Austria, October 3-5, 2012.
47. Nagi El Saghir. Metastatic Breast Cancer Updates. Iraqi Society of Medical
Oncology ISCO. Hilton Conference Center, Istanbul, Turkey, August 24, 2012
48. Nagi El Saghir. Management of Breast Cancer in Arab Countries and
Worldwide: Resources, Guidelines and Implementation. 6th Inter-American Breast
Cancer Conference IABCC, Cancun, Mexico, July 25-28, 2012
49. Nagi El Saghir. Bisphosphonates in Breast Cancer. Breast Cancer sessions. Best
of ASCO 2012, Beirut, Lebanon, Phoenicia Hotel, June 21-22, 2012
50. Nagi El Saghir. Medical Treatment in Metastatic Breast Cancer: Hormonal
Therapy and Guidelines. PACC-12: Pan Arab Cancer Congress -12, Tunis,
Tunisia, April 27-28, 2012.
51. Nagi El Saghir. HER2-positivity in neo-adjuvant breast cancer therapy.
Lebanese Society of Medical Oncology – CME program. Beirut, Lebanon, April
24, 2012.
52. Nagi El Saghir. Neo-adjuvant therapy for patients with locally advanced and
large primary breast cancer: two case presentations, interactive discussion, and
recommendations. 8th Annual Meeting of the Lebanese Society of Medical
Oncology and Congres d’Oncologie Francophone (LSMO-COF), Le Bristol,
Beirut, Lebanon, April 20, 2012.
53. Nagi El Saghir. Update on Breast Cancer in Lebanon. Congress by the Lebanese
Society of Ob/Gyn, Societe d’Infertilite Francophone, and Institut Curie, Paris,
France. Bellevue Medical Center, April 14, 2012, Mansourieh, Lebanon, April 14,
2012
54. Nagi El Saghir. Antiangiogenic therapy in breast cancer. Angiogenesis Course:
ANGIOGENESIS BIOLOGY, BASIC PRINCIPLES & CLINICAL
APPLICATIONS, Beirut, February 24-25, 2012, Lebanon.
55. Nagi El Saghir. Clinical Practice Guidelines. NCCN Middle East North Africa
Meeting, January 26-28, 2012, Doha, Qatar
56. Nagi El Saghir. Hormonal Therapy for premenopausal patients with breast
cancer. Breast & Gynecological International Cancer Conference (BGICC),
January 12-13, 2012, Cairo, Egypt.
57. Nagi El Saghir. Best of San Antonio Breast Cancer Conference: Bone Health,
January 4-5, 2012, Jeddah, Saudi Arabia
58. Nagi El Saghir. Best Practices in Primary Breast Cancer. American College of
Surgeons Annual Conference, Lebanese Chapter, December 2011.
59. Nagi El Saghir. Managing Breast Cancer in Low- and Middle- Income Countries.
Advanced Breast Cancer ABC1 International Consensus Conference, Lisbon,
Portugal, November 3-5, 2011
60. Nagi El Saghir. Early Breast Cancer: State of the Art. Masterclass in Clinical
Oncology, Euro-Arab School of Oncology, Amman, Jordan, October 27-29, 2011.
61. Nagi El Saghir. Breast Cancer 2011 Year-in-Review: UAE Cancer Congress,
October 6-8, 2011, Dubai, United Arab Emirates.
62. Nagi El Saghir. Tailoring upfront therapy for metastatic breast cancer. EuroAsian Forum on Oncology. September 3-4, 2011, Moscow, Russian Federation.
63. Nagi El Saghir. Adjuvant Chemotherapy and hormonal therapy for small breast
tumors. Euro-Asian Forum on Oncology. September 3-4, 2011, Moscow, Russian
Federation.
64. Nagi El Saghir. New Trends of diagnosis and management of breast cancer in the
Middle East. Euro-Asian Forum on Oncology. September 3-4, 2011, Moscow,
Russian Federation.
65. Breast Cancer updates/ Chemoprevention: Best of ASCO 2011, Beirut, Lebanon,
July 1-2, 2011
66. Actualites dans le traitment neo-adjuvant du cancer du sein et therapie ciblee. Le
2eme Congres d’Oncologie Francophone, Beirut, Lebanon, May 13-14, 2011
67. Neo-adjuvant therapy of breast cancer in 2011. Pan Arab Cancer Congress,
Casablanca, Morocco, April 28-29, 2011
68. Adjuvant therapy of breast cancer: special issues. Pan Arab Cancer Congress,
Casablanca, Morocco, April 28-29, 2011
69. Breast Cancer update 2011. Lebanese Society of Internal Medicine 6th Annual
Meeting. Movenpick Hotel, Beirut, Lebanon, March 2011.
70. Adjuvant therapy for small tumors. Womens’ Cancer symposium, MD Anderson
Cancer Center – AUB Medical Center NK Basile Cancer Institute – King Hussein
Cancer Center Combined Symposium. Beirut, LB, January 2011.
71. Best of San Antonio SABCS 2010 presentations, Riyadh, Saudi Arabia, 2011.
72. Adjuvant chemotherapy versus endocrine therapy alone in primary breast cancer.
BGICC Annual Breast Gynecology International Cancer Conference, Cairo,
Egypt, January 2011.
73. Neglected versus non-neglected Locally Advanced Breast Cancer: Poster
presentation at SABCS, San Antonio, TX, December 2010.
74. Breast Cancer Panel: Memorial Sloan Kettering Cancer Center and Lebanese
Society of Medical Oncology Annual Meeting, Le Royal Hotel, Beirut, Lebanon,
November 2010
75. Management of the patient with HER2 positive breast cancer in 2010. UAE
Cancer Congress, Dubai, United Arab Emirates, October 28-30, 2010
76. Breast Cancer in Arab Countries: International Young Women Cancer
Conference. September 30 - October 1, 2010, Damascus, Syria
77. Downstaging Breast Cancer in Arab Countries and Africa: Wayne State
University Global Health Conference on Downstaging Breast and Cervix Cancers
in Africa and Middle East. October 5-8, 2010.
78. Locally Advanced Breast Cancer: Update. 2010 Bi-Annual Meeting of the Jordan
Oncology Society. July 29-31, 2010, Amman, Jordan
79. Locally Advanced Breast Cancer in Arab countries and Breast Health Global
Initiative. InterAmerican Breast Cancer Conference IABCC-5, July 8-11, 2010,
Cancun, Mexico.
80. Utilization of MultiDisciplinary Tumor Boards in Arab Countries. Global Summit
on International Breast Health: Optimizing HealthCare Delivery. June 9-11, 2010,
Chicago, Illinois, USA
81. Triple Negative Breast Cancer Management Update. 10th Pan Arab Breast Cancer
Congress, Algiers, Algeria, May 2, 2010
82. Breast cancer panel guidelines for HER2 positive disease. Breast and GYN
Oncology International conference. Cairo, January 28, 2010.
83. Standards of Care and Guidelines for the Arab World: Initiative to Improve
Cancer Care in the Arab World. Riyadh, Saudi Arabia, March 23-25, 2010
84. Tobacco Control: Initiative to Improve Cancer Care in the Arab World. Riyadh,
Saudi Arabia, March 23-25, 2010
85. Breast Cancer in Lebanon and Arab Countries. American University of Beirut
Faculty Research Symposium. March 6, 2010
86. Best of San Antonio 2009 Breast Cancer Conference. Adjuvant chemotherapy
session. January 6-7, 2010. Riyadh, Saudi Arabia.
87. Breast Health Care in Low and Middle Income Countries: Allocation of
Resources for Diagnosis and Treatment (With NS Bese). Middle East Oncology
Congress, Lebanese Cancer Society COMO 8, Beirut, Lebanon, November 5-7,
2009
88. Prevention and Early Detection of the most common cancers. Middle East
Oncology Congress, Lebanese Cancer Society COMO 8, Beirut, Lebanon,
November 5-7, 2009
89. Recent advances in the diagnosis and management of breast cancer. Hamad
Medical Corporation, Al-Amal Hospital. Doha, Qatar, October 18, 2009.
90. Breast Cancer Update: Together towards overcoming breast cancer (Public
Lecture). Qatari breast cancer screening campaign. Grand Regency Hotel
Conference Center. Doha, Qatar, October 17, 2009.
91. Targeting the ErbB2 receptor in breast cancer. Al-Amal Hospital Department of
Oncology Invited Lecture, Doha, Qatar. October 17, 2009.
92. Breast Cancer. Principles of Medical Oncology Conference. August 6-7, 2009.
Hamah, Syria.
93. Best of ASCO Breast Cancer abstract presentations. July 7-8, 2009. Beirut, LB
94. Breast cancer in Arab world. Pan Arab Cancer Congress PACC-9. May 7-9, 2009.
Cairo, Egypt.
95. Treatment of Metastatic Breast Cancer: An Overview. 42nd Middle East Medical
Assembly, Beirut, Lebanon, April 23-26, 2009
96. Update on Epidemiology and Management of Breast Cancer. South Lebanon
Hospitals, Tyr, Lebanon, April 11, 2009.
97. Treatment of Breast Cancer. Alaeddine Hospital, Sarafand, South Lebanon,
March 28, 2009
98. Breast Cancer Prevention and Management Update. AUB Department of
OB/GYN Grand Rounds, Wednesday March 25, 2009.
99. Tailoring Therapy and Surgery for Breast Cancer. Grand Rounds. Department of
Surgery. AUB. Monday, March 6, 2009.
100.
Tailoring Therapy for Breast Cancer. Grand Rounds. Department of
Internal Medicine. Tuesday, February 20, 2009.
101.
Breast Cancer: Al-Amal Annual Cancer Conference, Doha, Qatar,
February 2009
102.
2009
Breast Cancer Highlights, Best of SABCS, Riyadh Saudi Arabia, January
103.
Neo-adjuvant therapy in Breast Cancer. Lebanese Society of General
Surgery. Lebanese Order of Physicians. January 31, 2009.
104.
Epidemiology and Early Detection of Breast Cancer in Lebanon and Arab
Countries. World Health Organization WHO EMRO Intercountry Meeting for
Cancer Control. Cairo, December 15-18, 2008
105.
Targeting HER2/neu Receptors: Issues and Toxicities. Contemporary and
New Advances in Oncology. Jordan Oncology Society and Arab Medical
Association Against Cancer. Amman, Jordan, November 6-8, 2008.
106.
Breast cancer early detection and prevention. 2nd Annual Meeting on Early
detection of Cancer, Riyadh, Saudi Arabia, October 21-23, 2008
107.
Nagi El Saghir, Angelo Di Leo (Chairs). WHICH TOOLS CAN I USE IN
DAILY CLINICAL PRACTICE TO IMPROVE TAILORING TREATMENT
FOR BREAST CANCER. Breast Cancer Educational Session. 33rd European
Society of Medical Oncology ESMO Annual Meeting. Stockholm, Sweden,
September 12-16, 2008
108.
Epidemiology and Prevention of Cancer in Arab Countries. 33rd
European Society of Medical Oncology ESMO Annual Meeting. Stockholm,
Sweden, September 12-16, 2008
109.
4th InterAmerican Breast Cancer Conference IABCC. Global Public
Health and Epidemiology. Trends of Breast Cancer in Arabic Countries. Cancun,
Mexico, July 24-26, 2008.
110.
3rd Best of ASCO in Lebanon. Highlights of the day and Early Breast
Cancer. Selections and Highlights of ASCO 2008, Chicago, Il. Faraya, Lebanon,
July 11-12, 2008
111.
For Your Health, My Lady.! Treatment of Breast Cancer. Opening
Ceremony, Launching of Kuwait Breast Health Awareness Website, Kuwait and
Gulf Radiology Imaging Conference. Kuwait, Kuwait, February 10, 2008, with
Nour-el-Huda Karmani (Early Detection)
112.
Cancer du Sein de A a Z. Paradis d’Enfants Women’s Group Awareness
Lecture; February 1, 2008, Dbayeh, Lebanon
113.
Best of San Antonio Breast Cancer Symposium. Adjuvant therapy,
Worldwide EBCTG Overview; Breast Cancer in Young Women in Arab
Countries
114.
Breast Cancer in Arab countries: Management and prospects. Princess
Noora Oncology Center International Breast Cancer Syposium, Jeddah, Saudi
Arabia, November 2007
115.
Breast Cancer Panel Case Discussion, Breast Cancer Symposium, Dead
Sea, Amman, Jordan, October 2007
116.
Update on targeted therapy and management of GIST. Iraqi Oncology
Symposium, Dead Sea, Amman, Jordan, October 2007.
117.
Treatment of Locally Advanced Breast Cancer in Countries with Limited
Resources. Breast Global Health Initiative 3rd Global Summit, Budapest,
Hungary, October 1-4, 2007
118.
Breast Cancer in Arab countries: Trends of epidemiology and
management. Johns Hopkins Cancer Center Tumor Board Conference, September
5, 2007
119.
Breast Cancer presentations. Highlights of the Day presentations. Best of
ASCO 2007, Cairo, Egypt
.
120.
Breast Cancer Awareness Campaigns and Novelties: LIONS Club
International Jordan, Iraq, and Lebanon. Amman, Jordan, June 15, 2007.
121.
Breast Cancer in young women. MEMA-Hopkins Breast Cancer Course,
May 12, 2007.
122.
Nagi Saghir and Nagi Khoury: Breast Cancer worldwide and in Arab
Countries. MEMA-Hopkins Breast Cancer Course, May 11, 2007.
123.
Introduction to Breast Cancer. AUB Biology Student Society. West Hall,
AUB, April 20, 2007.
124.
Breast cancer in Arab Countries. Kuwait International Primary Breast
Cancer Conference, March 31-April 2, 2007.
125.
Breast Cancer in Young Women. Grand Rounds, Department of Internal
Medicine Grand Rounds, AUB, February 13, 2007
126.
2007
Best of San Antonio 2006 in Riyadh, Saudi Arabia: Breast cancer, January
127.
Best of ASCO 2006 (Breast cancer), Beirut, Lebanon, November 2006
128.
Nagi El Saghir, et al. Trends of epidemiology and care of breast cancer in
Arab countries. UICC, July 8-12, 2006, Washington, DC.
129.
Breast Cancer in Emerging Countries: Breast Cancer in the Arab World.
European Breast Cancer Conference EBCC-5, Nice France, March 21-24, 2006.
European Journal of Cancer supplement 2006, Vol 4 No 2 page 180 (abstract
444).
130.
Chemotherapy for Breast Cancer. Iraqi Oncology Workshop 2006, Le
Bristol Hotel Conference Center, May 10, 2006, Beirut, Lebanon,
131.
Breast Nodule, assessing risk. Breast Cancer for the General Practitioner
in 2006. Fourth Annual Meeting of the Lebanese Society of General Practice,
Lebanese Order of Physicians Headquarters, April 7-8, 2006, Beirut, Lebanon
132.
Systemic Treatment of Breast Cancer: Adjuvant therapy. Euro Arab
School of Oncology Course on Advances in Clinical Oncology. March 6-7, 2006,
National Training Institute, Cairo, Egypt
133.
Breast Cancer update. First Annual Internal Medicine Joint Review
Course. American University of Beirut and Johns Hopkins University, Rotana
Hotel Conference Center, February 1-4, 2006, Beirut, Lebanon
134.
New choices for adjuvant chemotherapy in node-positive breast cancer.
Breast Cancer: Special Issues in Young Women. European School of Oncology
Advanced Course, September 30 – October 1, 2005, Beirut, Lebanon.
135.
Breast Cancer Screening in the Middle East. Breast Cancer: Special Issues
in Young Women. European School of Oncology Advanced Course, September
30 – October 1, 2005, Beirut, Lebanon
136.
Recent rise in the incidence of breast cancer in Lebanon. NCI-UICCAMAAC Conference: Cancer in the Developing World, March 21-25, 2005,
Cairo, Egypt.
137.
Trends in Breast Cancer in Lebanon: January 4, 2004. Grand Rounds,
Department of Obstetrics and Gynecology, AUBMC.
138.
Breast Cancer in Lebanon. Faculty Research Club, American University
of Beirut Medical Center, January 26, 2004, Beirut, Lebanon.
139.
Screening for Breast and Prostate Cancers. Core Curriculum Lecture.
AUBMC Department of Internal Medicine. February 3, 2004.
140.
Breast Cancer in Lebanon data. Faculty Research Club. AUB Department
of Internal Medicine. January 26, 2004.
141.
Screening and treatment of breast cancer in Lebanon. Grand Rounds,
Division of General Surgery, AUBMC, March 21, 2004.
142.
Targeted therapy for cancer. Commentator for Grand Rounds by Buthaina
Dabaja, MD. Department of Internal Medicine, AUBMC, Beirut, Lebanon, March
21, 2004.
143.
Breast Cancer in Lebanon. Pan Arab Cancer Congress, April 4-8, 2004,
Kuwait, Kuwait.
144.
Screening for breast cancer in young women in Lebanon. Lebanese
National Research Council - Lebanese Atomic Energy Commission –
International Atomic Energy Association conference on Tumor Markers in
Cancer. April 25-28, 2004, Beirut, Lebanon.
145.
Cancer Screening in Private Practice: First Annual Symposium of the
Lebanese Society of Internal Medicine LSIM on Private Practice Patient Care:
Pain Management and Cancer Screening in the private office, February 20, 2003.
LSIM, Lebanese Order of Physicians Headquarters, Beirut, Lebanon.
146.
Treatment of locally advanced and metastatic NSCLC lung cancer: Case
presentation and interactice discussion. AUB Educational Symposium. March 15,
2003, Mzaar, Faraya, Lebanon.
147.
Breast Cancer in Lebanon and Middle East: Jordanian Cancer Society
Conference in Istanbul, August 29-30, 2003, Istanbul, Turkey.
148.
Adjuvant therapy for early breast cancer in 2003. Pan Arab Cancer
Congress, October 21, 2003, Damascus, Syria.
149.
Evidence-Based Medicine Breast Cancer Symposium. Take home
messages. Nagi Saghir, MD. Lebanese Cancer Society, November 2003.
150.
Recent advances in targeting cancer: CML, GIST, and more. Medical
Grand Rounds, March 25, 2003. Department of Internal Medicine, American
University of Beirut Medical Center
151.
Cancer Screening Update: 4th Annual Pan Arab Cancer Congress, Doha,
Qatar, April 2002.
152.
What’s new in breast cancer screening. AUB 3rd Educational Symposium.
September 3, 2002. Mzaar, Faraya, Lebanon.
153.
Current Recommendations for Cancer Screening. Special Lecture,
American Alumni Association of Lebanon and Trad Hospital, Haigazian
University. January 23, 2002
154.
Breast Cancer: Recent Advances and Guidelines. Grand Rounds,
Department of Internal Medicine, AUBMC Medical Center. Tuesday, January 9,
2001
155.
Gastro-Intestinal Lymphoma: Treatment of Primary Small Intestinal
Lymphoma. ASCO-PANARAB Lymphoma Conference. November 9, 1999,
Cairo, Egypt.
156.
Recent Update on Breast Cancer: American University of Beirut Medical
Center – Department of Medicine: Medical Grand Rounds, March 1999.
157.
Fever, Arthritis and Lymphadenopathy: AUBMC Medical Grand Rounds
(Amer El-Sayyid, MD & Nagi Saghir, MD), November 1999.
158.
Update on Lung Cancer: American University of Beirut: Department of
Internal Medicine Grand Rounds, March 1998
159.
GM-CSF for Pressure Ulcer Accelerated Wound Healing. Hematology
Conference, Department of Hematology-Oncology, Wayne State U., Detroit, MI,
May 1997
160.
Cancer care and statistics in Lebanon and the Arab World. Grand Rounds,
Department of Hematology-Oncology, Karmanos Cancer Center, Wayne State
University, Detroit, Michigan, May 14, 1997
161.
Recent Advances in Oncology: Update for the General Internist.
American University Hospital-Department of Internal Medicine Grand Rounds,
April 1997
162.
Treatment of Cancer of Salivary Glands: Lebanese ENT Society Spring
Meting, Tripoli, Lebanon 1996
163.
Interferon in Cancer Therapy. American University Hospital-Department
of Internal Medicine Grand Rounds, February 1996
164.
Treatment of Pain in Cancer Patients: American University HospitalDepartment of
Obstetrics and Gynecology Grand Rounds (with other speakers) February 1996
165.
Lung Cancer Prevention and Therapy. American University HospitalDepartment of Internal Medicine Grand Rounds, 1995
166.
Treatment of Small Intestinal Lymphoma: 2nd Middle East Oncology
Congress COMO II, May 1995
167.
Blood Transfusion Indications: Annual Meeting of the Lebanese AIDS
Society, Beirut, Lebanon 1995
168.
Treatment of In-Situ Breast Cancer: American University of Beirut,
Department of Surgery, Grand Rounds, December 1995
169.
Recent advances in breast cancer. 19th International Convention, National
Arab American Medical Association, June 28-July1, 2004, Beirut, Lebanon
170.
Shamseddine AI, Bitar N, Dheini M, Chehal A, Abou Mrad Y, Jalloul R,
Dandashi A, Wehbe M, El Saghir N. Cisplatinum/ Navelbine followed by
taxotere in metastatic breast cancer. Proceedings European Breast Cancer
Conference EBCC-4, abstract # 27, 2004 Hamburg, Germany.
171.
El Saghir N, Shamseddine A, Geara F, Rahhal B, Salem Z, Taher A,
Abbas J, Bikhazi K, Khalil A, Hourani M, Charafeddine M, Seoud M. Breast
Cancer: Increased age adjusted incidence rates in younger-aged groups at
presentation in Lebanon and Arab countries. Implications for screening and for
Europeans, Australians and Americans of Arabic origins. Abstract # 456,
Proceedings European Breast Cancer Conference, Hamburg, Germany, March 1420, 2004.
172.
El Saghir N, Shamseddine A, Geara F, Rahhal B, Bikhazi K, Abbas J,
Salem Z, Khalil A, Hourani M, Seoud M. Breast Cancer in Lebanon. Proceedings
of the 3rd Arab American Health Conference, Detroit Michigan, October 25-27,
2003.
173.
El Saghir N. Recent trends of cancer in Lebanon. Proceedings of the 3rd
Arab American Health Conference, Detroit Michigan, October 25-27, 2003.
174.
Nagi Saghir: Adjuvant therapy of early breast cancer in 2003.
Proceedings of the Pan Arab Cancer Congress, Damascus, Syria, October 19-23,
2003.
175.
Nagi El Saghir: PACC-4: Cancer Screening. General Principles and
selected examples: Lung, Breast, colorectal and prostate cancers. Proceedings of
the 4th Pan Arab Cancer Congress, pages 51-56, Doha, Qatar, March 28-31, 2002
176.
Nagi El Saghir. Gastro-Intestinal Lymphoma: Treatment of Primary
Small Intestinal Lymphoma. Educational Book, American Society of Clinical
Oncology ASCO-PANARAB Lymphoma Conference, November 1999, Cairo,
Egypt. Pages: 119-122
C-2:
Awareness Campaigns Activities and Lectures:
20. ABC of Breast Diseases Book Debate & Discussion: Beirut International Book
Fair, with Rola Mouawad, Azza Mroueh, Mirna Hoballah and Dr. Karam Karam.
BIEL, Beirut, Lebanon.
21. Book Signing: ABC of Breast Diseases: Beirut International Book Fair, BIEL,
Beirut, Lebanon, December 8, 2013.
22. Book Signing: ABC of Breast Diseases: Sharjah International Book Fair, Sharjat,
United Arab Emirates, November 16, 2013.
23. On Beirut Roofs, Breast awareness, with Dalia Dagher, OTV, Beirut, October
2013
24. BBeirut: Breast Cancer Awareness. LBCI, October 2013.
25. Raising Awareness Breast Health: Citibank staff meeting, Citibank, Beirut,
October 2013.
26. Human Pink Ribbon: October Breast Awareness Campaign: AUBMC Breast
Center of Excellence and Lebanese Breast Cancer Foundation. October 5, 2013,
Greenfield, AUB, Beirut, Lebanon.
27. “I wear pink for my mother”: LBCF annual Mother’s day celebration. March
2013, Movenpick Hotel, Beirut, Lebanon.
28. “ABC” MISSION PINK: Awareness, Early Detection and advances in breast
cancer therapy: ABC conference for the Press and Media. MOH October
Campaign. October 12, 2012.
29. Pink Raouche: Lebanese Breast Cancer Foundation, AUBMC and Beirut
Municipality: Raouche, October 6, 2012. Awareness, early Detection and
Celebration of Survivorship. Press coverage and Interviews (LBC, OTV, MTV,
Future, Arabia, Jazeera, MBC (October 7, 8 and 9, 2012), , Annahar (October 8,
2012), Assafir (October 8 and October 13, 2012), AlAkhbar (October 3, 2012),
AlAnwar (October 8, 2012), Snob, Radio Liban, AlAfkar (October 15, 2012),
AlKifah AlArabi (October 2, 2012), Nadine, AlShark, Voice of Lebanon (October
15, 2012, … )
30. Health Awareness and Breast Cancer Early Detection. Mawlawi Cultural Center
and Lebanese Breast Cancer Foundation. Tripoli, Lebanon, May 12, 2012
31. Breast Cancer Awareness. Lebanese Breast Cancer Foundation Avant-Premiere
Movie Theatre, Taxi Al-Balad, February 29, 2012, Les Dunes, Verdun, Beirut,
Lebanon.
32. Mother’s Day and Mother’s Breast Health: Mother’s Day Brunch, Lebanese
Breast Cancer Foundation and NKBCI Breast Center of Excellence, March 19,
2012, Falamanki Café, Beirut, Lebanon
33. ASCO Connection July 2013:
http://connection.asco.org/Magazine/Article/ID/3606/2013-Best-of-ASCO-Lebanon-Timely-Oncology-Updates-and-Celebrations-in-the-Middle-EastDespite-Political-Instabilities-and-Turmoil.aspx
34. The ASCO POST: September 1, 2012:
http://www.ascopost.com/issues/september-1-2012/despite-challenges,-initiativesbring-gradual-improvements-to-cancer-care-in-lebanon.aspx
35. ASCO Connection online exclusives November 2012:
http://connection.asco.org/Magazine/Article/ID/3373/Lebanon-Lights-Up-inPink-its-Landmark-Raouche-Rocks-in-the-Middle-of-the-Mediterranean-Sea.aspx
36. Special articles and recent awareness campaigns and cancer control related
interviews: AUBMC Websites, Assafir, Annahar, Mother & Child, Snob, Special,
Al-Hasnaa, The Arab Hospital Magazine, Middle East Airlines Cedar Wings, AlKifah Al-Arabi, Al-Mawed, MTV, LBC, NBN, TL, Future, Al-Jazeera, AlArabia, etc , etc
1
El-Saghir N: ASCO Foundation International Travel Grants Program: A
mentor’s perspective. ASCO News July 2004.
http://www.asco.org/asco/downloads/asconews_july04.pdf
2
Nagi El Saghir. Breast Cancer in Lebanon and Worldwide: A global
health priority. ASCO News Quarterly Magazine. April-June 2003.
http://www.asco.org/asco/downloads/apr_news03.pdf.
37.
D) Current Research, Grants and Publications in Progress:
1-Prinicipal Investigator at AUBMC:
1- BRCA-1 and BRCA-2 mutations in Ethnic Lebanese Arab Women with breast cancer
(Ethnic Research Initiative – Sponsored by GSK: International Grant of $250.000): 20112013. Just published.
2- PALB2 and other genetic mutations in Ethnic Lebanese women with high risk breast
cancer for genetic mutations (ongoing).
3- Utilization and Efficiency of Tumor Boards at the American University of Beirut Medical
Center. Analysis in progress.
4- ASCO Tumor Boards international survey: Survey completed, manuscript submitted for
publication.
5- BCIRG 005 and BCIRG 006: Completed and published, updated.
6- BOLERO-1 International Phase III Clinical Trial: RAD001 in HER2-positive metastatic
breast cancer: Trial completed and just published.
7- BOLERO-6 International Phase II trial: Everolimus vs Capecitabine vs Everolimus plus
Exemestene in hormone receptor positive metastatic breast cancer.
8- PERUSE: International Post marketing Clinical Trial: Pertuzumab + Trastuzumab +
Taxane in HER2-positive metastatic breast cancer
9- Outcome of LABC Breast Cancer outside of clinical trials: Main part published in 2014.
Analysis of LABC is still ongoing.
10- MONALEESA 7 International Phase III Randomized Clinical Trial of ribociclib (CDK
4/6 inhibitor) with ovarian function suppression and tamoxifen or aromatase inhibitor in
premenopausal women with hormone receptor positive metastatic breast cancer: Ongoing
and actively recruiting.
11- MONALEESA 3: International phase III clinical trial of ribociclib (CDK 4/6 inhibitor)
with fulvestrant in recurrent hormone receptor positive metastatic breast cancer in postmenopausal women: In progress.
2- Co-Investigator:
Several projects in collaboration with members of the Division of Hematology-Oncology and
NK Basile Cancer Institute at AUBMC.
E) Teaching at AUB:
1- MED II:
Physical Diagnosis: (1994 - Present)
Introduction to Hematology: Lectures (1994-Present):
Myeloproliferative Disorders:
- Chronic Myeloid Leukemias
- Polycythemia Vera
- Essential Thrombocythemia
- Agnogenic Myeloid Metaplasia
- Chronic Lymphoid Leukemia.
Introduction to Hematology: Seminars (1994-2013); Team-Based Learning TBL: (2014Present):
Anemias: Iron deficiency, megaloblastic anemias, hemolytic anemias, anemias of chronic
diseases; WBC Disorders: Bone Marrow Failure and Acute Leukemias; Chronic Leukemias,
Platelet Disorders, Coagulopathies, Lymphomas, Transplantation, Targeted Therapy.
2- MED III & IV (1993-Present):
- Daily Teaching Rounds
- Attending of the Day Rounds
- Core Curriculum Lectures
- Ward Rounds: 5 South and Ain Wazain
- Grand Rounds: See special sections
3- INTERNS, RESIDENTS & FELLOWS: Teaching Rounds, Core Curriculum Lectures,
Grand Rounds Lectures and Ward Rounds.
4- Other teaching activities and communications:
Invited Lectures and Grand Rounds: See also: pages 10-15: Section 3
(Section 3: Invited Speaker/ Grand Rounds / Invited Reviewer / International conferences
F) SERVICE
1) Service to the University
- AUB University Publications Committee (2006-2008)
- AUBMC Patient Education Committee (2006-2008)
AUB University Publications Committee 2004-2006
- AUB Curriculum Committee 1999-2001
- Quality Assurance Committee (American University Hospital 1993-1995)
- Blood Utilization Committee (American University Hospital 1995-1997)
- AUB Hospital Committee on Cancer: 1995-Present
-AUB Hospital Committee on Cancer Educational Symposia: Organization and lecture
presentations (2001-2004)
- Cancer Registry: 20 years of service (Major Contributor). Edited by Dr. Ali Shamseddine, 2004
- AUB Breast Tumor Clinic Coordinator: 2002-Present
- AUB Medical Center Medical Committee 2000-2003, 2003-2005
- AUB MEMA (Middle East Medical Assembly):
Scientific Committee, 1999, 2001.
Business Committee, 2003-2004.
Organizing Committee, MEMA 2005.
Publication Committee, Chairman MEMA 2005
Organizing Committee, MEMA 2006
Publications Committee, Chairman, MEMA 2006
Organizing Committee, MEMA 2006, 2007
Scientific Committee and Oncology Sub-committee (MEMA 2007 and 2009)
- Library Committee: 2011-2013.
- Medical Staff – Board of Trustees Liaison Committee (2009-2011)
- AUB BCC1: February 14-15, 2013
- AUBMC BCC2: February 14-15, 2014
- AUBMC BCC3: February 13.14, 2015: Example from AUBMC website:
Examples of coverage at AUB/AUBMC website:
http://www.aubmc.org/Pages/The-Breast-Cancer-Center-at-AUBMC-Holds-Its-3rdBreast-Cancer-Conference-AUBMC-BCC3.aspx
AUBMC medical researchers work to unravel the mysteries behind breast cancer in young
women : the age of 40, noted Dr. Nagi El Saghir, clinical professor of medicine and director of
the … Finally, Zgheib and Saghir currently head up a research team that partnered with
Institut … Authors: Josiane Haddad Date: 10/21/2013 Size: 65KB
http://www.aubmc.org.lb/Pages/AUBMC-researchers-unravel-mysteries-breast-cancer.aspx
Launch of the National Breast Cancer Awareness Campaign at AUBMC under the patronage of
Lebanon’s First Lady and Minister of Public Health
Under the high patronage and presence of the Lebanese First Lady Mrs. Wafaa Sleiman, the …
Professor Nagi El-Saghir, director of breast center at AUBMC’s NKBCI and the president of …
Authors: Josiane Haddad Date: 10/7/2013 Size: 62KB
http://www.aubmc.org.lb/Pages/National-Breast-Cancer-Awareness-Campaign-AUBMC.aspx
2- Service to the community:
- Regular guest for press interviews and community conferences, , Medicine and Society
(Arabic & English magazines and newspapers), Public Education, selected Newspapers,
Magazines, Public Radio and TV, Awareness campaigns, antismoking campaigns, cancer
early detection;
-
Fundraising and patient support thru the Lebanese Breast Cancer Foundation at AUBMC:
-
Examples:
http://www.aubmc.org/Pages/AUBMC’s-Naef-K--Basile-Cancer-Institute-receivesgenerous-donation-from-The-Lebanese-Breast-CancerFoundation.aspx#sthash.8YIkegSi.dpbs
LBCF Donates 28,000$ for Breast Cancer Treatment at AUBMC’s NKBCI: In Lebanon, 1700
women patients are diagnosed with breast cancer each year, half of whom … Breast Center of
Excellence at the NKBCI and President of the LBCF, Professor Nagi El Saghir. Authors: Shireen
Makarem Date: 1/22/2013 Size: 60KB
http://www.aubmc.org.lb/Pages/LBCF-Donates-28,000$-for-Breast-Cancer-Treatmentat-AUBMC’s-NKBCI.aspx
Annual Mother’s Day Breast Health Awareness Event: Al-Mawed Magazine:
http://www.almawed.com/article/%D9%85%D8%AC%D8%AA%D9%85%D8%B9/%D8
%A7%D9%84%D8%AD%D9%81%D9%84%D8%A7%D9%84%D8%B3%D9%86%D9%88%D9%8A%D9%84%D9%80%C2%AB%D8%AC%D9%85%D8%B9%D9%8A%D8%A9%D9%85%D9%83%D8%A7%D9%81%D8%AD%D8%A9%D8%B3%D8%B1%D8%B7%D8%A7%D9%86%D8%A7%D9%84%D8%AB%D8%AF%D9%8A%C2%BB
Breast Cancer Awareness Campaign and Fundraising in Abu Dhabi, United Arab
Emirates: Coverage in Al-Mawed Magazine:
http://www.almawed.com/article/%D9%85%D8%AC%D8%AA%D9%85%D8%B9/%D8
%AD%D9%85%D9%84%D8%A9-%D8%AA%D9%88%D8%B9%D9%8A%D8%A9%D9%88%D8%B9%D8%B4%D8%A7%D8%A1%D8%AE%D9%8A%D8%B1%D9%8A%D9%84%D9%84%D8%AC%D9%85%D8%B9%D9%8A%D8%A9%D8%A7%D9%84%D9%84%D8%A8%D9%86%D8%A7%D9%86%D9%8A%D8%A
9-%D9%84%D9%85%D9%83%D8%A7%D9%81%D8%AD%D8%A9%D8%B3%D8%B1%D8%B7%D8%A7%D9%86%D8%A7%D9%84%D8%AB%D8%AF%D9%8A-%D9%81%D9%8A%D8%A3%D8%A8%D9%88%D8%B8%D8%A8%D9%8A
-
Over 400 publications and interviews: Most of them are currently on the web.
Founder & President, Lebanese Breast Cancer Foundation.
3-Service to the Profession:
a) Lebanon & Middle East:
Hospitals’ Committees, Symposia, Conferences, Congresses, University Committees and
activities, Lebanese Order of Physicians, Arab Medical Association Against Cancer, Arab
Initiative to Improve Cancer Care in Arab Countries, NCCN-Middle East North Africa Region
guidelines, BHGI, Best of ASCO, ASCO, ESMO, ESO, and others (See above)
b) Service to the Profession and International Communities:
ASCO and International activities:
Lebanon and Middle East: Best of ASCO Chair and Co-Chair: 2006-2014
Yearly Event organized by the Lebanese Society of Medical Oncology, licensed by ASCO:
International Activities: ASCO, ESMO, UICC, WHO, Middle East, Lebanon
ASCO Member: 1984-present
ASCO International Affairs Committee member: 2002-2005
ASCO IAC Chair-Elect: 2012-2013; Chair: 2013-2014, Immediate Past-Chair 2014-2015.
ASCO International Travel Grant Working Group, member, 2003-2004, 2004-2005
ASCO International Development Education Award (IDEA) working Group 2005-06
ASCO MCMC (Multidisciplinary Cancer Management Course) Working Group: 2011-present
Chair, ASCO International Affairs Committee (2013-2014)
Co-Chair, ASCO Guidelines Advisory Group, American Society of Clinical Oncology (2013)
Member, ASCO Global Oncology Task Force (2014-2015)
Member, ASCO / ESMO Global Curriculum task Force
President, and Co-Chair, Best of ASCO (2006-2015)
ASCO JCO International Editor, Middle East and North Africa
Editorial Board, Journal of Global Oncology
ASCO Highlights (LSMO) Chairman: 1997-2005
Best of ASCO (LSMO & ASCO) Chair, Co-Chair, and President: 2006-2015
ASCO Annual Meeting speaker 2013 on ASCO International
ASCO Annual Meeting speaker 2014 on Multidisciplinary Tumor Boards.
ASCO Connection articles: See above.
ESMO National Representative
ESMO Regional representative
ESMO Developing Countries Task Force
ESMO Emerging Countries Committee (Present)
BHGI: Summits, Panels, Speaker, Writer, Author
WHO: Technical meetings, advisor, Cairo, Geneva
UICC: EML / Breast Cancer Chapter contributions
Current Address, appointments, certifications, activities, and awards:
Nagi S. El Saghir, MD, FACP, Professor of Clinical Medicine
Division of Hematology-Oncology, Department of Internal Medicine
Director, Breast Center of Excellence, Naef K. Basile Cancer Institute
American University of Beirut Medical Center
P.O. Box: 11-0236, Riad El Solh 1107 2020, Beirut - Lebanon
Telephone: AUB: +961 1 350 000, Fax: AUB: +961 1 351 706, Mobile: +9613827955
Email: [email protected]; [email protected]
www.saghironline.com, www.aub.edu.lb, www.aubmc.org, www.breast-awareness.org